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Background. Persistent depression (PDD) is a difficult to treat condition with 
poor outcomes. There is a growing evidence base for psychological treatment 
for PDD and it is recommended there is an interpersonal element to therapy. 
However, much is still to be discovered about the relevant moderating and 
mediating variables involved in successful treatment. Group psychotherapy is 
thought to be as effective as individual therapy for Major Depressive Disorder 
but little is known about any possible advantages in treating PDD. Cognitive 
Analysis System of Psychotherapy (CBASP) was developed by McCullough 
(2000) to specifically treat PDD and involves a cognitive, behavioural, 
psychodynamic and interpersonal approach. Research has shown it to be 
effective at reducing depression symptoms and increasing interpersonal 
functioning in both individual and group formats. Interpersonal learning 
acquisition is measured in CBASP and it is theorised that this precedes 
symptom improvement as a person learns to apply the skills out-with the 
therapy room.  
Purpose. A systematic review and meta-analysis sought to compare group 
and individual psychological therapy to establish if there was any advantage 
to group therapy in individuals with PDD. An empirical study reviewed the 
outcome data from 13 groups of CBASP (CBASP-G) which was delivered in 
an outpatient setting to examine the process of change. 
Methods. A systematic review of the literature identified randomised controlled 
trials (RCT) that used psychological therapy for PDD. Twenty studies met the 
inclusion criteria, and a meta-analysis was performed to compare the 
effectiveness of group and individual therapy using post mean effect sizes. 
Studies were checked for risk of bias. Subgroup analyses were used to 
investigate the impact of moderators such as control type (active or inactive) 
and depression type (chronic depression or dysthymia). Outcome data from 
CBASP-G was gathered for the empirical study and extracted and analysed 
 v 
using paired t-tests and multilevel modelling statistical methods. Overall 
effectiveness, pattern of change of symptoms (overall distress and mood), skill 
acquisition, interpersonal functioning and global measures of improvement 
were examined in the analysis. 
Results. Group psychotherapy was found to have a moderate significant effect 
compared with a small effect for individual therapy, and the subgroups were 
significantly different. However, the sample had substantial heterogeneity and 
moderator analyses found that type of depression, control, and risk of bias 
were important factors when considering the results. In the empirical study 
CBASP-G was found to significantly improve depression, distress and mood 
symptoms. Significant change was found in the hostile-submissive 
interpersonal domain. Multilevel modelling revealed that skill acquisition 
improved the model fit significantly, but not all types had a significant result. 
Change was found to be linear for symptoms and quadratic for skill acquisition. 
Discussion. The thesis findings give preliminary evidence that psychological 
treatment for PDD is effective and that there may be an advantage to group 
delivery. Additionally, it gives some support to McCullough’s (2000) model that 
CBASP-G is an effective treatment for PDD, and skill acquisition is important 
in facilitating interpersonal change and symptom improvement. The review 
indicates that higher quality studies and further research are required to 
examine the impact of variables and moderators that are likely to have an 
impact on any differences between group and individual treatment. Longer 
follow up would help investigate the role of skill acquisition and routine analysis 









Introduction. Depression is the biggest cause of disability worldwide. Around 
a third of people that suffer from depression have it long term. This type of 
depression can be hard to treat and is called persistent depression (PDD). 
There is growing evidence that psychotherapy can treat PDD, but little is 
known about the factors that make treatment effective. Group therapy offers 
an opportunity for interpersonal learning which has been shown to be 
important in treating people with PDD. Cognitive Analysis System of 
Psychotherapy (CBASP) is specifically designed to treat PDD, and it can be 
delivered in an individual or group format. This therapy helps the person to 
learn how their interactions in relationships can be unhelpful and it encourages 
them to try a different approach which can help them have better results and 
make them feel better. 
Aims and methods. The first part of this thesis combines research studies for 
PDD that use individual and group formats to see if there is any difference in 
efficacy. The second part of the research is to find out if learning the skills in a 
group version of CBASP (CBASP-G) makes people feel less depressed and 
distressed. Data from 80 people who attended a group at an outpatient clinic 
was examined to look at the patterns of change in symptoms. A statistical 
method called multilevel modelling was used to do this, by applying different 
models to the data to see what factors were important. Understanding the 
process of change during therapies helps to make treatment better for those 
that need it. 
Main findings. Group psychological therapy was found to be more effective 
than individual therapy, but the difference could be due to a number of factors. 
These include the type of depression, type of therapy and control used. 
CBASP-G was effective at reducing depression and distress symptoms. The 
learning in CBASP-G appeared to be important for the reduction in symptoms 
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but longer follow and more high-quality research will be required to improve 
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Chapter 1 Meta-analysis 
1.1 Abstract 
 
Background. Persistent depressive disorder (PDD) is a debilitating condition 
which puts a heavy burden on mental health services. PDD is more difficult to 
treat than episodic depression and has poorer outcomes from treatment. 
Individuals with PDD typically have impoverished interpersonal functioning, 
and it is theorised this is linked to experiences of childhood maltreatment. 
Group psychotherapy has some advantages compared to individual therapy 
including being cost effective and allowing more people to be treated per 
therapist. Meta-analyses have found evidence that individual and group 
therapy for depression are similar in efficacy. Research points to there being 
an additional interpersonal benefit for group therapy. Little is known about any 
differences in effect of group or individual treatment for PDD. This exploratory 
meta-analysis was designed survey the literature to compare the effect of 
group versus individual psychological therapy for PDD and consider the effect 
of possible moderators. 
Methods. A systematic search of the literature was completed to source 
randomised controlled trials (RCT) of psychotherapy for PDD. Twenty studies 
met the criteria for inclusion. Studies were assessed for risk of bias using the 
RoB2 software and inter-rater reliability tested for the sample. Data was 
extracted from the 20 studies with post therapy mean effect sizes used to 
compare psychotherapy for PDD versus a control. A meta-analysis was carried 
out to compare group versus individual treatment for PDD. Subgroup analyses 
were carried out to examine the impact of type of control (inactive or active), 
type of PDD (chronic depression or dysthymia), and risk of bias. 
Results. There was a significant difference found in favour of group treatment 
in the 20 studies found. A small mean effect size was found for individual 
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therapy (14 studies with 31 different arms) d= 0.27 (95% CI: -0.42, -0.11), 
Z=3.34, (p<0.001), and heterogeneity was I2=77% (p<0.001) compared with a 
moderate mean effect size for group delivery (6 studies with 13 different arms) 
d=-0.53 (95% CI: -0.80, -0.26) Z= 3.83 (p<0.001) and heterogeneity of I2=60% 
(p<0.01). Testing for subgroup differences highlighted there was a significant 
difference between individual and group therapy using the p-value of 0.10 to 
assess for heterogeneity (I2 = 63.3%, p=0.10). Analysis for publication bias 
found no concerns. Most studies had an element of risk of bias. Further 
moderator analyses explored the impact of outliers, type of depression and 
control type (active or inactive).  
Conclusions. Group therapy for PDD demonstrated an advantage over 
individual therapy. There were many confounding variables which affected this 
analysis and their impact is unclear. Type of control, type of depression and 
quality of study were all likely confounding factors. The type of therapy and 
dose of sessions were not accounted for but likely important in their impact. 
Limitations and suggestions for future research are discussed. 
Keywords. Persistent depressive disorder (PDD), Chronic depression, 
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1.2 Introduction  
 
Caspi & Moffitt (2020) found that the majority of people will experience a 
mental health disorder in their life, but most will have more than one and a 
variety of issues, therefore, mental health problems should be expected. The 
impact of early onset disorders on the increase of number and variety of mental 
health problems means that early intervention and prevention is important. 
Depression is a global concern, with persistent depressive disorder (PDD) 
having worse outcomes and a poorer response to treatment than other types 
of depression (Jobst, et al., 2015; World Health Organisation (WHO), 2020). 
This paper will review the current evidence base for treatment of PDD and look 
at different types of delivery by individual or group therapy modes. The aim of 
the study is to systematically review randomised controlled trials (RCT’s) of 
psychological treatments for persistent depression and perform a meta-
analysis to investigate if there are any benefits from group treatment compared 
to individual treatment. The results are presented and future directions for 
research are suggested. 
 
1.2.1 Depression impact prevalence and factors 
Depression is one of the most frequently occurring mental health problems and 
is estimated to affect around 6.9% of the population (Wittchen et al., 2011) or 
264 million people globally (Sheikh et al., 2018) making it a global priority 
(WHO, 2020). Prevalence has been rising in the UK since the start of the 
COVID-19 pandemic, with up over 20% of UK adults reporting symptoms of 
depression in the first half of 2021 (Office for National Statistics (ONS), 2021). 
The burden of depression is extensive, with it being one of the biggest 
contributors to disability worldwide (Wittchen et al., 2011). 
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1.2.2 Persistent/chronic depression and dysthymia 
Around a fifth to a third of people with depression are thought to have a chronic 
course, lasting over two years and from around a third to a half of people 
utilising specialist mental health services are estimated to have PDD 
symptomology (Arnow & Constantino, 2003; Klein & Santiago, 2003; Rubio et 
al., 2011; Torpey & Klein, 2008). PDD differs from episodic depression in that 
the depressive symptoms should be present for at least 2 years with less than 
8 weeks remission. It can be characterised as either early or late onset 
(before/after age 21) (American Psychiatric Association (APA), 2013). Chronic 
depression was the term commonly used for this type of depression until it was 
recently re-classified as PDD in the Diagnostic and Statistical Manual of Mental 
Disorders 5th edition (DSM-5) (American Psychiatric Association, 2013). PDD 
is classified as either dysthymia (persistent mild depression), chronic 
depression, double depression (Major Depressive Disorder (MDD) with 
dysthymia), and recurrent MDD with incomplete recovery between episodes 
(Schramm et al, 2008). International Classification of Diseases 11th revision 
(ICD-11) use a coding system to define the persistent element of MDD and 
use similar definitions of 2 years without remission (World Health Organization, 
2018). Research has suggested that dysthymia is similar to chronic 
depression, or indeed, part of the same disorder leading to it being combined 
into PDD (American Psychiatric Association, 2013; Klein & Santiago, 2003; 
Torpey & Klein, 2008). However, there is some dispute over the validity of the 
concept of dysthymia as research has showed there is significant overlap with 
MDD and anxiety disorders with the suggestion that dysthymia combines PDD 
with an anxiety disorder, and links this to neurotic personality traits (Hidalgo et 
al., 2012; Klein et al., 2000; Rhebergen & Graham, 2014). Treatment-resistant 
depression (TRD) differs from PDD and is generally defined as not responding 
to two doses of antidepressant medications of an “adequate” dose and 
duration (Fava, 2003).  PDD and TRD can be loosely defined in studies and 
while they are similar concepts a patient may fit one of the definitions or both. 
The pooling of TRD and PDD can be problematic as the concepts are different 
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and therefore treatment effects could be different (Cuijpers et al., 2020, Jobst 
et al., 2015). 
 
People experiencing PDD are more likely to have social and economic 
impairments, earlier age of onset, lower self-esteem, poor overall health, more 
likely to have suicide attempts, higher healthcare usage, more co-morbid 
health conditions and less likely to respond to anti-depressant medication 
compared to non-chronic courses of depression (Jobst, et al., 2015; Köhler et 
al., 2019; Rubio et al., 2011; Schramm et al., 2006). The same is roundly true 
for those with a diagnosis of dysthymia with most eventually developing major 
depression episodes during their lifetime (Klein et al., 2000).  Indeed, the 
individual, family and societal impact is widespread with higher co-morbidities 
of other mental health and medical problems than those with non-chronic 
depression (Köhler et al., 2019; Murphy & Byrne, 2012). 
 
There are various factors that have been implicated in the development of PDD 
including childhood maltreatment (neglect, emotional/sexual/physical abuse), 
(Cicchetti & Barnett, 1991, Lizardi et al., 1995; Wiersma et al., 2009). However, 
the evidence for the impact of childhood maltreatment is mixed with a recent 
review finding the link inconclusive (Köhler et al., 2019). Deficits in 
interpersonal functioning has been found to be more prevalent in persistent 
forms of depression and studies have found this factor is important in how PDD 
is maintained (Leader & Klein, 1996). Bird et al. (2018) and Köhler et al. (2019) 
found that socially avoidant styles were linked to PDD rather than episodic 
depression and this finding builds on previous research that decreases in 
hostile-submissive traits improved depression symptoms (Constantino et al., 
2008; Constantino et al., 2012).  
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1.2.3 Treatment for PDD 
Treatment rates for mental health problems are low with Wittchen et al. (2011) 
finding that less than a third of people in Europe received support for their 
mental health condition. Worldwide it is estimated in lower income countries 
that only 15-24% receive any treatment for depression (Wang et al., 2007). 
Reduced social support is a predisposing factor for depression which can 
interfere with a person’s ability to navigate treatment and could make them 
more likely to drop out of treatment (Keller et al., 2014). Treatment resistance 
has been linked with higher suicide risk, co-morbid anxiety, more 
hospitalisations, childhood maltreatment, higher doses of anti-depressants 
and longer depressive episodes (DeCarlo et al., 2016; Nanni et al., 2012). 
Arnow & Constantino (2003) argue that long term treatment is required to 
ensure full recovery and prevent relapse and they highlight that work and social 
functioning may take longer to improve than depressive symptoms alone. 
 
1.2.3.1 Types of interventions 
1.2.3.1.1 Medication 
Anti-depressant medication is a recommended treatment for PDD and its use 
is steadily increasing (Kendrick et al., 2021). More than 10% of adults in 
England were prescribed anti-depressants (for varying reasons) in March 2018 
alone (NHS Digital, 2019). However, there are issues with relying on 
medication for treatment with the rates of remission for PDD patients being 
less than 30% (Ijaz et al., 2018; Krystal et al., 2011; Trivedi et al., 2006). It is 
possible the true rates of remission are even lower since the RCT trials that 
provide the evidence lack ecological validity, such as excluding participants 
with co-morbid disorders, which are extremely prevalent in PDD (Trivedi et al., 
2006). Also, withdrawal and side effects from anti-depressants, (such as 
problems with sleep, weight gain and sexual dysfunction), are common, can 
be severe, and can be mistaken with depression symptoms in measures such 
as the HDRS-17 and BDI-II (Hieronymus et al., 2021; Kendrick et al., 2021; 
Saha et al., 2021).  
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1.2.3.1.2 Psychological therapy 
Psychological therapy is often a preferred treatment method and 
recommended psychological interventions for treating persistent depression 
include CBT, Inter-personal psychotherapy (IPT), behavioural activation, and 
Cognitive Behavioural Analysis System of Psychotherapy (CBASP). (The 
Matrix, 2015; McHugh et al., 2013; National Institute for Clinical Excellence 
(NICE), 2009). The evidence base for treating PDD with psychotherapy has 
been demonstrated in previous meta-analyses (Cuijpers et al., 2010; 
Furukawa et al., 2018). Cuijpers et al. (2010) first combined the RCT data on 
chronic depression and dysthymia in a meta-analysis compared by type of 
control (inactive, active, combined treatment). They found a significant small 
effect for psychotherapy compared with inactive controls, but psychotherapy 
was less effective than pharmacotherapy. However, the studies that brought 
down the effect size were dysthymia treatment studies indicating that either 
that dysthymia was less receptive to the psychotherapy offered or more 
responsive to medication (Cuijpers et al. 2010).  
 
It is important to note that there are issues with operationalising RCT’s into real 
world settings (Schindler et al., 2011). Indeed, Riihimaki et al. (2017) found 
that only half of depressed primary care patients who needed maintenance 
treatment received it, and then for less time that was recommended, thus 
putting the patient at increased risk for relapse and decreasing the impact of 
treatment. Research suggests the dose of treatment is important for PDD and 
that intensive but also prolonged treatment is warranted, with Cuijpers et al. 
(2010) suggesting 18 sessions were a minimum amount (Dunner, 2001; 
Schramm et al., 2019). This is an important feature as Schramm et al. (2015) 
highlighted that certain interpersonal behaviours such as being extremely 
passive, or aggressive are not explicitly dealt with in some types of therapy like 
IPT while the CBASP manual directly addresses this point. 
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1.2.3.1.3 Combined treatment 
Evidence points to combination treatment of psychotherapy and medication 
being the most effective and desirable treatment (Arnow & Constantino, 2003) 
and the European Psychiatric Association recommend combined treatment 
with an interpersonal element (Jobst et al., 2015). Cuijpers et al. (2020) 
demonstrated that combined treatment is most effective for chronic and 
treatment resistant depression with recommendations that if only one mode of 
treatment is available then psychotherapy should be offered over medication. 
Unfortunately, this is not the case routinely with many people not getting any 
suitable treatment for PDD (Koscis et al., 2008). Guidi et al. (2020) suggest a 
sequential approach to reduce recurrence of depression is to integrate 
psychotherapy after acute phase medication and this can be alongside 
continued medication. They highlight the importance of increased 
psychological well-being while removing residual symptoms as being key to 
this. Cuijpers et al. (2020) found that acceptability of treatment (defined as drop 
out for any reason) was highest in combined treatment, then psychotherapy 
alone was more acceptable than medication alone. This may be due to 
increased risk of side effects in medication and patient preference leaning 
towards psychotherapy rather than medication treatment (McHugh et al., 
2013). Long term follow up also shows that for depression combined treatment 
is more effective than medication alone and psychotherapy more effective than 
medication (Cuijpers et al., 2020; Cuijpers et al., 2013), however, there is a 
paucity of long term follow up studies and more data is required to investigate 
this. Research points to combined treatment effect being independent parts of 
both treatments rather than a true combined effect (Cuijpers et al., 2014). 
 
1.2.3.2 Group treatments 
Group psychotherapy originates from when a physician treating a few 
individuals how to manage tuberculosis, observed spontaneous peer support 
occurring in the sessions (Freedheim, et al., 1992). Indeed, there appear to be 
many advantages of group delivery of psychotherapy including reduced costs 
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and therapist time and being able to treat more people at once (Morrison, 2001; 
Tucker & Oei, 2007). Group CBT for depression has been found to be cost 
effective compared with individualised therapy but there is a lack of high-
quality studies using comprehensive costing models to give a definitive answer 
on the scale of the cost effectiveness, and for some conditions (e.g. alcohol 
and substance misuse) individualised therapy may be more cost effective 
(Tucker & Oei, 2007).  Fogarty, et al., (2019) found group CBT was not only 
economical and effective at reducing symptoms of social anxiety and 
depression but that the symptom improvement was sustained over the long-
term indicating the participants developed skills of becoming their own 
“therapist”. Additional benefits have been cited in the literature and include 
improved interpersonal functioning, a positive impact of a cohesive group, peer 
modelling, and participants obtaining a shared understanding of the difficulties 
they are experiencing (Lewinsohn & Clarke, 1999; Morrison, 2001). In a more 
recent study on young people who had experienced domestic violence the 
group format enabled a gradual feeling of safety within the group which was 
thought to allow the process of accepting and giving of support to others. 
Furthermore, a strength of this format was thought to be the enhanced 
opportunity to talk through how their complex family relationships had affected 
them (Fellin, et al., 2019). Yalom & Leszcz (2005) highlight that this giving and 
receiving support cultivates a stronger, therapeutic alliance than one would 
see in individual therapy and the identification with others in the group fuels 
sharing and insight into one’s own issues. This process is thought to allow the 
development of social and communication skills and even support individuals 
to be able to receive criticism (Yalom & Leszcz, 2005). 
 
However, there are some disadvantages including the reduced ability to 
personalise the treatment to the individual’s needs, risks of a person 
dominating the sessions or subgroups forming which could interfere with the 
group’s overall progress, (Morrison, 2001; Tucker & Oei, 2007). Furthermore, 
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the group environment may make it harder for some to disclose personal 
thoughts that might help with progress in therapy (Morrison, 2001).  
 
Cuijpers et al. (2019) network meta-analysis on CBT for depression found 81 
of 101 studies were delivered in individual format, despite evidence that 
psychotherapy is also effective across group, internet or guided self-help 
delivery models.  There were no significant differences between acceptability 
of different methods of CBT treatment when comparing individual, group, and 
telephone CBT, though, guided self-help was less preferred than individual 
therapy (Cuijpers et al., 2019). Cuijpers et al. (2020) recommend that 
alternative modes of treatment such as group therapy should be used in 
routine practice.  
 
Group treatment such as CBASP for PDD has been shown to reduce 
depression symptoms and increase interpersonal functioning (Sayegh et al., 
2012; Locke et al., 2017). Locke et al. (2017) noted the fear their group 
participants had at evoking anger or scorn from others, and this made it difficult 
for them to assert themselves at the start of therapy, though this changed as 
the group treatment progressed. This points to there being an added benefit to 
group delivery in practicing difficult social circumstances with others who have 
similar problems, and that the group environment can offer a conducive, safe 
atmosphere to do this (Sayegh et al., 2012). However, there appears to be a 
lack of research on comparisons of different delivery modes of therapy for 
PDD. 
 
1.2.4 Rationale for meta-analysis 
As depression rates are rising, partly due to the impact of COVID-19 pandemic 
(ONS, 2021), and with PDD patients using disproportionately more mental 
health services, cost and time effective solutions are vital to meet this burden 
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(Torpey & Klein, 2008). Group therapy is effective at treating many mental 
health problems, has advantages in being more cost effective, with a potential 
peer interaction benefit and has been shown to be effective for PDD (Locke et 
al., 2016; Morrison, 2001; Sayegh et al., 2012; Tucker & Oei, 2007). 
Additionally, no significant difference was found between individual and group 
CBT therapies for non-chronic types of depression (Cuijpers et al., 2019). PDD 
is difficult to treat and there may be added advantages to the group set up that 
benefits those with PDD who likely have interpersonal difficulties (Jobst et al., 
2015; Pettit et al., 2008). Therefore, this study aimed to explore this topic by 
systematically reviewing the literature for RCT’s that treat PDD and comparing 
the effectiveness between group and individual modalities through a meta-
analysis. The impact of moderators such as control type or depression type 
were examined.  It was hypothesised that psychotherapy for PDD would be 




1.3 Methods  
 
1.3.1 Identification and selection of studies 
1.3.1.1 Inclusion criteria 
Studies in English which included RCT’s of psychotherapy for 
persistent/chronic depression. The DSM-5 criteria for persistent depression 
was used with studies meeting the criteria for one of the following: 
- Chronic/persistent depression 
- double depression (MDD with dysthymic disorder) or  
- recurrent depression with incomplete remission between episodes 
- dysthymia  
 
   
Meta-analysis comparing the effectiveness of group and individual 
psychological therapy for PDD.  13 
all lasting for 2 years or longer. No age limit was selected. Psychotherapy was 
defined as psychologically informed intervention. 
 
The term “chronic depression” (DSM-IV) is used to combine chronic/persistent 
depression, double depression and recurrent depression with incomplete 
remission between episodes and separate from dysthymia. These terms 
“chronic depression” and “dysthymia” are used in the analysis below. 
 
1.3.1.2 Exclusion criteria 
Studies which were not available in English or did not have post mean data 
available were excluded. Studies where the participants did not meet the PDD 
criteria were also excluded. 
 
1.3.1.3 Literature search strategy 
A literature search was carried out using the following databases and date 
range: APA Psych articles full text (to 4th December, 2020), Embase Classic 
and Embase (1947 to 4th December, 2020), Ovid MEDLINE(R) and Epub 
Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations 
and Daily (1946 to 4th December, 2020), and PsycInfo (1806 to 4th December, 
2020). 
 
The search was carried out in each database using the following search terms: 
(("chronic* depress*" or "persist* depress*" or "treat* resist* depress*") OR 
("chronic MDD" or "chronic major depress* disorder" or "recurrent MDD" or 
"recurrent major depress* disorder" or "dysthymi*") OR (“depress*neurosis” or 
“refractory depress*” or “treatment resist* depress*”). AND ("therap*" or "inter*" 
or "psycho*therap*"). AND ("random*" or "rct") ab,ti. The analysis was 
registered on Open Science Framework (OSF) (osf.io/72fa8). 
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The search terms were tested to pick up known papers from other meta-
analyses (e.g., Cuijpers et al., 2010, Cuijpers database Open Science 
Framework (OSF), 2019) and terms adjusted and added to fit (e.g., depressive 
neurosis and treatment resistant depression). Papers that met the inclusion 
criteria were searched for references of other studies and hand search 
completed of papers referring to chronic/persistent depression. Articles that 
were identified by search were screened and duplicates were removed (Figure 
1.) in accordance with PRISMA guidelines (Moher et al., 2009). Articles 
identified from other papers and that had been screened were compared with 
the inclusion/exclusion criteria. Those that met the criteria were included in the 
meta-analyses. Articles that were less clear about meeting inclusion criteria 
were checked with authora and a consensus was reached about inclusion. 
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Figure 1. PRISMA flow diagram (Moher et al., 2009). 
 
1.3.2 Risk of bias assessment 
The studies were assessed using the Cochrane revised risk of bias tool for 
randomized trials (RoB 2) (Sterne et al., 2019). This checked the validity of the 
studies for the following criteria: Randomisation process; Deviations from the 
intended interventions; Missing outcome data; Measurement of outcome; 
Selection of the reported result. Each study was ranked for each criterion as 
   
Meta-analysis comparing the effectiveness of group and individual 
psychological therapy for PDD.  16 
either Low risk, Some concerns, or High risk. Each study was then given an 
overall risk Low risk, Some concerns or High risk. This allowed for the studies 
to be rated accordingly for areas that are likely to produce bias (Higgins et al., 
2016). 
 
1.3.3 Meta-analyses and data extraction 
Data extraction was carried out by the first author, and a sample checked by 
the second author. Any discrepancies or studies that were unclear were 
discussed and agreed upon between authors. The effect size of difference 
between the psychotherapy intervention and the control (active or inactive) 
was calculated at post-test for each comparison using Cohen’s d standardised 
mean difference, since outcome measures were not all the same (Higgins et 
al., 2019). This was taken from the end of therapy depression score means 
and standard deviations. Few studies reported follow up data, so a decision 
was made to look at end of therapy alone. Size of effect was considered as 
follows: 0.2 = small; 0.5 = moderate; 0.8 = large (Cohen, 1988). Cuijpers et al. 
(2014) has suggested that a clinically meaningful cut off could be 0.24. 
Measures of symptoms of depression were used and if two outcomes were 
reported the independently assessed (non-self-report) one was used. The 
depression measure post mean was extracted with standard deviations (SD) 
for each intervention and control; in some studies, there were multiple arms for 
comparison. In studies with insufficient reporting of data, attempts were made 
to contact the authors and if the post-mean values could not be sourced the 
study was excluded from the meta-analysis.  
 
A series of meta-analyses were conducted utilising Review Manager 
(RevMan) 5 (2020) software to calculate the pooled mean effect sizes 
(standardised mean difference) from the post means and SDs (Higgins et al., 
2019). Since, significant heterogeneity was assumed likely due to errors within 
and between studies, and that the studies have variations in average effect 
   
Meta-analysis comparing the effectiveness of group and individual 
psychological therapy for PDD.  17 
size, a random effects model was used (Field, 2005a). The level of statistical 
significance was set at p< 0.05. Where combination of psychotherapy and 
medication was being compared to other therapy this was input with the 
experimental condition being the combination therapy. Similarly, when two 
therapies were being compared the experimental condition was compared with 
the other therapy as control. Analysis was performed by separating active 
controls (other therapy, medication) and inactive controls (waiting list, TAU, 
CAU, placebo). Some of the studies had multiple arms which duplicates the 
participant data and may artificially affect the heterogeneity or the effect size 
of the meta-analysis. A decision was taken to follow the procedure used by 
Cuijpers et al., (2010) and Cuijpers et al., (2011) in their meta-analyses looking 
at chronic depression and Interpersonal Psychotherapy for depression, of 
using multiple arms rather than combining arms, since the effect of the type of 
control was of interest to this study. Cuijpers et al., (2010 & 2011) carried out 
additional meta-analyses to look for any effects of using the multiple arms 
using one sample of the data for largest effect size and for smaller effect size. 
Likewise, an additional analysis was carried out using one sample of each 
participant group of data from each study - one carried out using the largest 
effect size and one using the lowest effect size. This did not significantly 
change the effect size of the overall result or reduce the heterogeneity which 
was still classed as high (Table 2.). 
 
The chi-squared test and I2 statistic was calculated to categorise the impact of 
heterogeneity in percentage on the ES estimates using the following levels of 
heterogeneity: 0 to 40% might not be important; 30-60% possible moderate; 
50-90% possible substantial; 75-100% possible considerable high. Caution is 
advised in using the chi-squared test alone due to lack of power and small 
sample sizes typical in meta-analyses and using the p-value of 0.1 is 
suggested rather than 0.05 to assess heterogeneity. (Higgins et al., 2003; 
Deeks et al., 2021). Sensitivity analyses was performed in each subtest to 
investigate the impact of possible outliers. Outliers were defined if the 95% CI 
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lay out with the mean pooled effect size for the meta-analysis. Subgroup 
analyses were calculated where possible to examine the impact of depression 
type (chronic depression or dysthymia) and control type (active or inactive). 
 
1.3.3.1 Other analyses 
Publication bias was evaluated by inspecting the funnel plot from the 
comparisons and performing a regression test for asymmetry of the funnel plot 
(Egger, 1997), file drawer analysis (Rosenthal (1995) approach), Duval & 
Tweedie (2000) trim and fill procedure, and a weight function model for 
publication bias (Vevea & Hedges, 1995). Inter-rater reliability was assessed 
for the risk of bias scoring. Supplementary analysis was completed using Shiny 
app for R (MAVIS; Hamilton & Mizumoto, 2017). The Cochrane Review 







Figure 2. Formula for combining means (SD’s) into one group (Higgins et al., 2019). 
 
 
1.4 Results  
 
A total of 3682 studies were found by the database and hand search. 684 
duplicates were removed. A total of 2551 studies were eliminated during the 
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abstract and title screening stage leaving 447 studies were subject to a full text 
examination. Twelve studies were rejected as they did not have the 
appropriate data available. Some of these authors were contacted (if the paper 
was within the last five years) but no extra data was provided by them. A total 
of 20 studies met the inclusion criteria and were used in the meta-analysis. 
Most studies were carried out in the Europe, US or Canada, with two studies 
out with this (Ebrahimi et al., 2013 (Iran), de Mello et al., 2001 (Brazil). 
 
All studies used validated depression measures with most studies using the 
clinician rated Hamilton (1960) depression scale (HRSD/HAM-D) and only four 
the studies using other measures (BDI-II (Ebrahimi et al., 2013, Strauss et al., 
2012) – two, MADRS (Browne et al., 2002) – one and IDS (Wiersma et al., 
2014) – one).  
 
1.4.1 Characteristics of included studies 
Within the 20 studies there was data from 2538 participants, of those 1708 
received a form of psychological therapy. Interventions included combinations 
of CBT (6 studies), CBASP (6 studies), IPT (7 studies), with utilisation of CBT 
based interventions BPT, MBCT, SIPT, psychodynamic therapy, LTPP, and 
non-specific control therapy BSP and SP (4 studies). Controls included 
combinations of active controls (medication (9 studies), other therapy (10)), 
and inactive controls (wait list (4), placebo (2), TAU or CAU (4)). The 
characteristics of the sample are shown in Table 1. The mean participants per 
study was 126.9. The number of sessions of therapy planned ranged from 8 to 
60 sessions with a mean (SD) of 19.3 (-12.5).  
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Table 1. Description of included studies 
Author 
Year 
















CBT 16 NR 31.3  
(6.4) 
16 US Clinical Chronic 
depression 
DSM III-R 
HDRS Individual M/Mo/T 
IPT 14 16 
Imipramine 20  
Placebo 15  
Browne 
(2002) 
IPT 83 68% 42.1 
(12.0) 
12 Canada Primary care DYS DSM-IV 
MDD 15% 
MADRS Individual Mo/T 
IPT/Sertraline 122 12 
Sertraline 117  
De Jong 
(1986) 
CBT 10 70 36.6 (7.5) 37 Germany Inpatient MDD and 







CT 10 50 
W/L 10  
Dunner 
(1996) 
CT 11 45.8 35.7 16 US NR DYS DSM-III HRSD Individual M/Mo/T 
Fluoxetine 13  
Ebrahimi 
(2013) 
SIPT 16 55 31.81 
(10.31) 
8 Iran  DYS DSM-IV BDI-II Individual M 
CBT 16 31.25 
(8.82) 
8 
W/L 15 29.06 
(9.5) 
 
Medication 15 32.26 
(10.36) 
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Author 
Year 




















HAM-D Individual T 
Moclobemide/TAU 13  
Fonagy 
(2015) 
LTPP/TAU 67 66.7 42.7 
(10.4) 




HRSD Individual M/Mo/T 
TAU 62 66.1 46.1 (9.9)  
Harpin 
(1982) 
CBT 6 41.7% 42.0  20 UK Clinical Chronic over 
2 years 
HAM-D Individual T 
W/L 6  
Keller 
(2000) 
CBASP 216 65.3 43 (10.7) 16 US Outpatients Chronic DSM-
IV 
HRSD Individual M/Mo/T 
CBASP/nefazadone 226 16 
nefazadone 220  
Koscis 
(2009) 
CBASP/medication 174 56 45.3 
(11.9) 
16 US Clinical Chronic DSM-
IV 
HAM-D Individual M/Mo/T 
BSP/medication 168 57.9 46.4 
(11.7) 
16 





IPT 23 63 42.3 
(12.3) 
16 US Community Early-onset 
DYS DSM-IV 
HAM-D Individual M/Mo/T 
IPT/sertraline 21 16 
sertraline 24  
BSP 26 16 
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Author 
Year 























BSP 12 16 
Michalak 
(2015) 
CBASP/TAU 35 62.9 50.2 
(10.5) 
8 Germany Community Chronic DSM-
IV 
HAM-D Group M/Mo/T 
MBCT/TAU 36 58.3 48.4 
(11.5) 
8 





CBT/sertraline 25 57.7 NR 12 Canada Community DYS DSM-
IIIR or DSM-
IV 
HAM-D Group T 
CBT/Placebo 24 12 
Sertraline 22  
Placebo 26  
Rohricht 
(2013) 
BPT 11 41.9 46.9 
(11.7) 
20 UK Outpatients Chronic DSM-
IV 
HAM-D Group M/Mo/T 
W/L 12 48.5 (9.1)  
Schramm 
(2017) 
CBASP 124 66 44.9 
(11.8) 
20 Germany Outpatients Chronic DSM-
IV 
HRSD Individual M/Mo/T 
SP 111 20 
Schramm 
(2008) 
IPT/medication 24 58.3 40.0 
(10.77) 











CBASP 13 57.1 40.2 
(11.5) 
22 Germany Outpatient Chronic DSM-
IV 
HRSD Individual M/Mo/T 
IPT 13 53.3 22 
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Author 
Year 
















PBCT/TAU 14 71.4 43 (10.6) 12 UK Outpatient Chronic DSM-
IV 
BDI-II Group Mo/T 
TAU 14  
Wiersma 
(2014) 
CBASP 53 68.7 41.1 
(10.8) 
24 Netherlands Outpatient Chronic DSM-
IV 
IDS Individual M/Mo/T 




M = Manualised treatment, Mo = Monitored treatment, T = Trained therapists, CBT = Cognitive behavioural therapy, IPT = Interpersonal therapy, NR = 
Not reported, HRSD = Hamilton rating scale for depression, MADRS = Montgomery Ashberg Depression Rating Scale, DYS = Dysthymia, CHR = 
chronic, W/L = Wait List, TAU = Treatment as usual, MDD = Major depressive disorder, CT = cognitive therapy with out behavioural part, BDI-II = Beck 
Depression , SIPT = Spiritual Integrated Psychotherapy, HAM-D = Hamilton rating scale for depression, LTPP = Long term psychoanalytic 
psychotherapy, BSP = Brief supportive therapy, SP = Non-specific supportive psychotherapy, CHR = chronic depression, CM = Clinical management, 
Chronic DSM-IV = fits criteria of …., PBCT = Person based Cognitive Therapy, CAU = Care as usual, IDS = Inventory of depressive symptomology 
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1.4.1.1 Sex 
All but one study reported sex data (Agosti et al., 1997) and percentage of 
female ranged from 31% to 80% with a mean (SD) of 59.42% (11.14). 
 
1.4.1.2 Age 
Age data was reported in all studies except de Mello et al., (2001) and 
Ravindran et al., (2000), while standard deviations were not reported in Dunner 
et al., (1996), Harpin et al., (1982), Markovitz et al., (2008). The average mean 
(SD) age of participants of studies that provided sufficient age data was 43.13 
(11.71). 
 
1.4.2 Group versus Individual therapies 
There were 4 studies in which the psychological treatment was delivered in a 
group format with two other studies utilising a mixed format of both individual 
and group elements (de Jong et al., 1986 & Schramm et al., 2008). These 
studies were included in the group analysis since it was assumed that any 
benefit from the group format would be included in these. A moderator analysis 
of type of delivery of therapy (group or individual) (Table 2. & Figure 6.) gave 
a small mean effect size for individual therapy (14 studies with 31 different 
arms) d= 0.27 (95% CI: -0.42, -0.11), Z=3.34, (p<0.001), and heterogeneity 
was I2=77% (p<0.001) compared with a moderate mean effect size for group 
delivery (6 studies with 13 different arms) d=-0.53 (95% CI: -0.80, -0.26) Z= 
3.83 (p<0.001) and heterogeneity of I2=60% (p<0.01). Testing for subgroup 
differences highlighted there was a significant difference between individual 
and group therapy using the p-value of 0.10 to assess for heterogeneity (I2 = 
63.3%, p=0.10) (Higgins et al., 2003; Deeks et al., 2021). (see Appendix B. for 
Forest plots). 
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A sensitivity analysis was performed by removing the studies which had group 
and individual treatment (de Jong et al., 1986 & Schramm et al., 2008). This 
did not have any significant impact on the result but increased the 
heterogeneity from  I2 =  60% to I2 = 69% and a change in ES from d = 0.53 to 
d = 0.51.  Using one ES per data set (highest and lowest) did not change the 
overall result with an advantage for group over individual therapy, but there 
were still high rates of heterogeneity and non-significant differences between 
the subgroups of group and individual treatment. A sensitivity analysis 
examining outliers was performed. In the individual analysis outliers were 
identified (Ebrahimi et al., (2013) CBTvW/L and SIPT v WL, Browne et al. 
(2002) (IPT), and Markovitz et al. (2005) IPT v MED. In the group treatment 
subgroup outliers were removed (Strauss et al., (2012), Ravindran et al. (2000) 
CBT v MED. The effect of removing the outliers reduced the heterogeneity 
from high to moderate in individual treatment and from high to zero 
heterogeneity in the group treatment subgroup. It did not have a significant 
effect on the mean effect size for each but did give a significant effect of 
difference between the two subgroups in the test for subgroup differences 
(I2=87.1%, p=0.005).  
 
1.4.2.1 Dysthymia or chronic depression subgroup analysis 
1.4.2.1.1 Dysthymia 
A subgroup analysis was performed to look at the moderating effect of type of 
depression (dysthymia or chronic depression). In the dysthymia subgroup of 
group treatment there was only one study with 5 arms (Ravindran et al., 2000) 
and the overall result was non-significant (d=-0.29, (95% CI: -0.80, 0.23), 
Z=1.10ns, I2=75%). While for individual treatment there was a moderate effect 
size (d=-0.42 (-0.79, -0.06), Z=2.26 (p<0.05), I2=86% (p<0.001). A 
subtest analysis revealed there was no difference between the individual and 
group treatment for dysthymia (I2=0%, p=0.67).  
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1.4.2.1.2 Chronic depression 
In the chronic depression subgroup of group treatment there were 5 studies 
with 8 arms of comparisons showing mean effect size d=-0.67 (95 CI: -0.95, -
0.39), Z=4.64, (p<0.001). Heterogeneity was lower than all group studies at 
I2=35%ns. A sensitivity analysis was performed taking out each study to 
observe any differences and taking Strauss et al. (2012) out brought 
heterogeneity to 0% and reducing the mean effect size from d=0.67 to d=0.55. 
In chronic depression individual treatment subgroup (10 studies with 17 arms) 
there was a smaller but significant effect of d=-0.24 (95% CI: -0.37, -0.12) with 
moderate heterogeneity than for all individual studies (I2=48%). Completing a 
sensitivity analysis in this subgroup by removing Keller et al. (2000) CBASP 
arm reduced heterogeneity to I2=20% and mean effect size from d =0.24 (95% 
CI: -0.37, -0.12) to d=-0.30 (95% CI: -0.41, -0.20).  
 
1.4.2.2 Active versus inactive controls 
Analysis was performed by separating active controls (other therapy, 
medication) and inactive controls (waiting list (W/L), TAU, CAU, placebo).  
1.4.2.2.1 Active control 
Active controls in individual treatment subgroup (11 studies with 24 arms) and 
group treatment subgroup (3 studies with 5 arms) gave a small mean effect 
size (individual d=-0.18 (95% CI: -0.33, -0.04), group d=-0.21 (95% CI: -0.63, 
0.22) but this was non-significant in the group treatment subgroup. There were 
no differences between the individual and group treatment groups (I2=0%, 
p=0.92). A sensitivity analysis delivered no meaningful difference in the 
outcome except with group treatment when Ravindran et al. (2000) CBTvMED 
was removed which changed the mean effect size to a significant one and 
heterogeneity to 0% (d=-0.39 (95% CI: -0.67, -0.12), I2=0%ns), while this did 
increase heterogeneity between the subgroups this change was not significant 
(I2=44.4%, p=0.18). With active controls in all comparisons there was no 
difference between individual and group. Only one outlier was found 
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(Markovitz et al., (2005) IPTvMED and this decreased heterogeneity by 2% to 
65%. 
 
1.4.2.2.2 Inactive controls 
Comparing group (5 studies and 8 arms) and individual treatment (5 studies 
and 7 arms) inactive controls delivered large mean effect sizes compared with 
active controls ((individual d=-0.88 (95% CI: -1.59, -0.17), group d=-0.74 (95% 
CI: -1.03, -0.46). Like the active controls, there was no difference between the 
subgroups (I2=0%, p=0.60).  
 
An exploratory analysis of removing the dysthymia studies (Ebrahimi et al., 
(2013) individual, Ravindran et al., (2000) group) was performed and reduced 
the mean effect size and heterogeneity of the individual treatment subgroup to 
d=-0.18 (95% CI: -0.40, 0.04), I2=0%, p=0.86, and made the result non-
significant. The removal of Ravindran et al., (2000) increased the mean effect 
size of the group treatment subgroup (d=-0.81 (95% CI: -1.18, -0.43) and this 
delivered a significant difference between the subgroups of inactive/chronic 
depression in favour of group treatment (I2=87.4%, p=0.005). A sensitivity 
analysis showed no meaningful differences of any other study arms being 
removed. 
 
1.4.3 Publication bias 
Publication bias was not found to be prevalent despite using different analysis 
techniques (see Appendix A. for Funnel plots). A trim and fill analysis using L0 
and Q0 variable suggested there were no missing studies (Figure 3 & 4.), 
however, using R0 there were two studies highlighted as “missing” but this did 
not significantly change the result. Funnel plot asymmetry was assessed using 
a weighted regression test with multiplicative dispersion using standard error 
as a predictor yielded a non-significant result (test for funnel plot asymmetry: t 
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(42)=-1.8308, p=0.0742). A file drawer analysis using the Rosenthal (1995) 
approach (Fail safe N: 1268) also indicated that a large number of non-
significant studies would not affect the overall meta-analysis result (Oswald & 
Plonsky, 2010). Furthermore, using a weight function model for publication 
bias gave an insignificant likelihood ratio test (X^2(d.f. = 1) = 0.3085674, 
p=0.57856 not indicating publication bias (Vevea & Hedges, 1995). 
  
Figure 3. Trim and fill analysis (L0) Figure 4. Trim and fill analysis (R0) 
 
1.4.4 Quality of included studies 
A sample of studies were co-rated for risk of bias by the second author. Inter-
rater reliability was 80% for scoring risk of bias. The agreement was moderate 
Kappa=0.412, and greater than expected by chance (z=2.38, p=0.0174) 
(Landis & Koch, 1977). Risk of bias was assessed using RoB2 software 
(Sterne et al., 2019) (Figure 5.) One study was “low” risk, nine studies had 
“some concerns” and 10 with “high risk” of bias. “Measurement of the outcome” 
category showed least risk of bias with only one study with high risk and four 
with some concerns. “Deviations from the intended interventions” was next 
least problematic with four studies high risk and one some concerns. “Missing 
outcome data” with 7 high risk and one some concerns. “Randomization 
process” had eight studies at a low risk of bias (4 high risk and 8 some 
concerns) and “Selection of the reported result” had the least amount of low 
risk studies 4, 2 high risk and 14 some concerns).  
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Table 2. Meta-analysis results for individual versus group therapy 
Comparison 









Individual versus group treatment 
Individual treatment 14 (31) -0.27 -0.42, -0.11 3.34*** 77%*** 0.10 63.3% 
Individual treatment outliers 
removed 
14 (27) -0.23 -0.35, -0.11 3.85*** 52%*** 0.005 87.1% 
One ES per data set - highest 14 (17) -0.32 -0.51, -0.12 3.16** 68%*** 0.09 65.4% 
One ES per data set - lowest 14 (17) -0.22 -0.45, 0.00 1.96o 74%*** 0.18 44.9% 
Group treatment 6 (13) -0.53 -0.80, -0.26 3.83*** 60%** 0.10 63.3% 
Group treatment outliers 
removed 
6 (11) -0.53 -0.71, -0.35 5.88*** 0% 0.005 87.1% 
One ES per data set - highest 6 (7) -0.67 -1.03, -0.31 3.68*** 51%o 0.09 65.4% 
One ES per data set - lowest 6 (7) -0.61 -1.13, -0.09 2.32** 76%*** 0.18 44.9% 
Subgroup Dysthymia 
Individual treatment 4 (14) -0.42 -0.79, -0.06 2.26* 86%*** 0.67 0% 
One ES per data set - highest 4 (6) -0.49 -1.18, 0.19 1.42ns 87%*** 0.50 0% 
One ES per data set - lowest 4 (6) -0.40 -1.19, 0.39 1.00ns 90%*** 0.78 0% 
Group treatment 1 (5) -0.29 -0.80, 0.23 1.10ns 75%** 0.67 0% 
One ES per data set - highest 1 (2) -0.22 -0.62, 0.18 1.08ns 0%ns 0.50 0% 
One ES per data set - lowest 1 (2) -0.16 -1.67, 1.35 0.21ns 92%*** 0.78 0% 
        
   
Meta-analysis comparing the effectiveness of group and individual psychological therapy for PDD.  31 
Comparison 









Subgroup chronic depression 
Individual treatment 10 (17) -0.24 -0.37, -0.12 3.78*** 48%* 0.007 86.2% 
One ES per data set - highest 10 (11) -0.33 -0.44, -0.22 6.01*** 2%ns 0.006 86.5% 
One ES per data set - lowest 10 (11) -0.14 -0.25, -0.03 2.50* 0%ns 0.010 85.1% 
Group treatment 5 (8) -0.67 -0.95, -0.39 4.64*** 35%ns 0.007 86.2% 
One ES per data set - highest 5 (5) -0.89 -1.27, -0.50 4.52*** 31%ns 0.006 86.5% 
One ES per data set - lowest 5 (5) -0.78 -1.25, -0.31 3.24** 54%o 0.010 85.1% 
Subgroup Active control 
Individual treatment 11 (24) -0.18 -0.33, -0.04 2.48* 69%*** 0.92 0% 
One ES per data set - highest 11 (12) -0.27 -0.45, -0.09 2.94** 52%* 0.25 25.5% 
One ES per data set - lowest 11 (12) -0.06 -0.26, 0.14 0.59ns 58%** 0.94 0% 
Group treatment 3 (5) -0.21 -0.63, 0.22 0.95ns 65%* 0.92 0% 
One ES per data set - highest 3 (3) -0.48 -0.79, -0.17 3.05** 0%ns 0.25 25.5% 
One ES per data set - lowest 3 (3) -0.09 -0.74, 0.56 0.27ns 76%* 0.94 0% 
Subgroup Inactive control 
Individual treatment 5 (7) -0.88 -1.59, -0.17 2.43* 88%*** 0.73 0% 
One ES per data set - highest 5 (5) -0.67 -1.36, 0.01 1.92o 85%*** 0.66 0% 
One ES per data set - lowest 5 (5) -0.65 -1.34, 0.04 1.84o 85%*** 0.60 0% 
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Comparison 









Group treatment 5 (8) -0.74 -1.03, -0.46 5.07*** 34%ns 0.73 0% 
One ES per data set - highest 5 (5) -0.85 -1.29, -0.42 3.84*** 47%ns 0.66 0% 
One ES per data set - lowest 5 (5) -0.87 -1.35, -0.40 3.65*** 54%o 0.60 0% 
Subgroup Risk of bias high risk 
Individual treatment 8 (21) -0.35 -0.62, -0.08 2.58* 76%*** 0.88 0% 
One ES per data set - highest 8 (11) -0.36 -0.75, 0.03 1.80o 75%*** 0.88 0% 
One ES per data set - lowest 8 (11) -0.35 -0.78, 0.09 1.55ns 79%*** 0.87 0% 
Group treatment 2 (7) -0.39 -0.81, 0.03 1.83o 66%** 0.88 0% 
One ES per data set - highest 2 (3) -0.32 -0.69, 0.05 1.70o 0%ns 0.88 0% 
One ES per data set - lowest 2 (3) -0.30 -0.67, 0.07 1.60ns 0%ns 0.87 0% 
Subgroup Risk of bias some/low risk 
Individual treatment 6 (10) -0.20 -0.39, -0.02 2.15* 79%*** 0.02 81.4% 
One ES per data set - highest 6 (6) -0.34 -0.49, -0.20 4.57*** 29%ns 0.02 80.3% 
One ES per data set - lowest 6 (6) -0.12 -0.33, 0.09 1.08ns 62%* 0.03 79.2% 
Group treatment 4 (6) -0.67 -1.02, -0.32 3.78*** 52%o 0.02 81.4% 
One ES per data set - highest 4 (4) -0.92 -1.39, -0.44 3.78*** 48%ns 0.02 80.3% 
One ES per data set - lowest 4 (4) -0.81 -1.39, -0.23 2.72** 66%* 0.03 79.2% 
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Key: 
o: p<0.10; ⁎: p<0.05; ⁎⁎: p<0.01; ⁎⁎⁎: p<0.001. ns= non-significant. 
N=number of studies, arms = number of comparisons 
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 Figure 6. Forest plot of group versus individual therapy. 
   
Meta-analysis comparing the effectiveness of group and individual 
psychological therapy for PDD.  35 
 
1.4.4.1.1 Active and inactive controls  
Active and inactive controls were analysed for the whole data set. A moderator 
analysis of control type displayed a larger effect for inactive controls (d=-0.80 
(-1.16, -0.44), Z=4.36 (p<0.001), I2=79% (p<0.001) compared to active 
controls (d =-0.19 (-0.32, -0.05), Z=2.72 (p<0.01), I2 = 67% (p<0.001) and 
confirmed the groups were statistically different. Comparing best case and 
worst-case scenario using one data set found a non-significant result for lowest 
data sets for active control, the difference between the subgroups held for all 
comparisons. Removing the inactive outliers (Ebrahimi et al., (2013) W/L arms) 
reduced the effect size from high to moderate (d=-0.50 from d=-0.88) and was 
still significant, with a significant difference between groups. Removing the 
active outliers (Ravindran et al., (2000) CBTvMED, Markovitz et al., (2005) 
IPTvMED, Browne et al., (2002) IPT, Keller et al., (2000) COMBvCBASP, 
Ebrahimi et al, (2013) SIPTvMED) maintained a significant effect and 
significant difference between the subgroups. Heterogeneity dropped from 
high to moderate by taking outliers out for both active and inactive subgroups. 
This held true with largest and smallest ES from study, though at worst case 
the ES is non-significant for active control. 
 
1.4.4.1.2 Chronic or dysthymia 
Analysis of type of depression was performed for the whole dataset. A 
moderator analysis for type of depression (chronic or dysthymia) produced 
similar effect size d=-0.38 (-0.68, -0.08) Z=2.49 (p<0.05), I2 = 84% (p<0.001) 
dysthymia and chronic depression d=-0.33 (-0.46, -0.21), Z=5.16 (p<0.001), 
I2=53% (p<0.01). There was less heterogeneity among the chronic depression 
studies (moderate compared to high) than the dysthymia studies. Testing for 
one ES per data set did not change the result significantly but the Z scores for 
dysthymia were non-significant. There was no heterogeneity between the 
depression groups indicating they were not significantly different. When 
comparing all the studies by type of diagnosis there was a small to medium 
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effect size which was significant but no difference between the subgroups. 
Removing the outliers (dysthymia – Ebrahimi et al., (2013) x W/L, Ravindran 
et al., (2000) CBTvMED, Markovitz et al., (2005) IPTvMED, Browne et al., 
(2002) IPT and chronic depression – Strauss et al., (2012), Keller et al., (2000) 
CBASP) made no significant difference to ES but lowered the heterogeneity 





1.5.1 Main findings 
This meta-analysis was designed to investigate if there is any advantage to 
psychotherapy in a group format, for people with PDD, compared with 
individual therapy. The main results support there is a difference between the 
group and individual therapies for PDD but there are many factors to consider. 
These are summarised below with the implications for theory, strengths and 
limitations and finally directions for future research are explored. 
 
1.5.1.1 Group versus individual treatment 
This analysis found a significant difference in the efficacy of group treatment 
for PDD compared to the individual treatments, with group treatment giving a 
moderate effect size and individual a small effect size. The difference between 
the groups was substantial and significant, but the heterogeneity within the 
group and individual treatments was significant. Removing the outliers reduced 
the heterogeneity for group treatment suggesting those results are consistent 
with each other. The majority of outliers were treatment for dysthymia and this 
could support that dysthymia should be considered separately from other types 
of PDD (Rhebergen & Graham, 2014). 
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1.5.1.1.1 Chronic depression and dysthymia subgroups 
The chronic depression subgroup maintained the significant finding and 
increased the effect size of group treatment to moderate to large. Using the 
highest ES maintained this result increasing effect size and lowest ES 
increased the group effect size to large and made individual treatment non-
significant. The dysthymia subgroup was non-significant with no discernible 
difference between them, but with only one study in group treatment this 
comparison should be disregarded due to lack of power. 
 
1.5.1.1.2 Inactive and active controls 
The inactive controls gave a significant large effect for both group and 
individual therapy with no difference between the groups, however, there was 
significantly less heterogeneity in the group treatment suggesting the group 
study effects are more similar than the individual ones. Removing the outlier 
(Ebrahimi et al., 2013) made the individual treatment subgroup effect non-
significant and made the difference between the individual and group 
treatment significant. Exploratory analysis revealed that inactive controls in 
treatment for chronic depression maintained a significant difference between 
group and individual treatment, with the individual effect non-significant. For 
active controls group treatment had a non-significant effect with no significant 
difference between the groups. Using highest ES made the results significant 
for both with a small effect for individual treatment and a moderate effect for 
group, but no difference between subgroups. There were 5 dysthymia studies 
in this analysis and a significant outlier (Ravindran et al., 2000). However, there 
were only 3 studies in the group treatment subgroup meaning the results 
should be considered with caution.  
 
1.5.1.1.3 Risk of bias 
The studies with a high risk of bias were homogenous and delivered a small 
to moderate effect size for both individual and group treatment but this was 
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not significant for group treatment. Studies with a lower risk of bias showed a 
significant difference between the group and individual treatment with a small 
effect for individual and moderate to large effect for group.  
 
 
1.5.2 Theoretical implications 
There was an overall small to moderate effect size for psychotherapy for PDD 
in all 20 studies and this compares with previous research (Cuijpers et al., 
2010; Furukawa et al., 2018). This meta-analysis found a difference in favour 
of group treatment between overall group and individual treatment effects for 
PDD. Importantly, the lower risk of bias studies maintained the significant 
advantage of group over individual psychological therapy indicating that high 
quality studies were more likely to reveal group benefits. This is different to 
Cuijpers et al. (2019) finding that for CBT for MDD  group treatment is equitable 
with individual treatment and could suggest that there is an advantage in 
offering group treatment to those with PDD but the result is to be taken with 
caution. The impact of outliers, poor quality and high-risk studies, dysthymia 
as a concept and type of active or inactive control appears significant. Many of 
the subgroup analyses are on a low number of studies and cannot be 
extrapolated.  
 
The reasons for the advantage of group therapy in this sample could be 
attributed to interpersonal benefits and positive peer impacts and further 
studies could be designed to test this out (Fellin, et al., 2019, Lewinsohn & 
Clarke; 1999, Morrison 2001, Yalom & Leszcz, 2005). This could challenge the 
dominance of individual treatment for PDD when group treatments are 
additionally acceptable and effective with added benefits of reduced cost and 
therapist time (Cuijpers et al., 2019; Morrison, 2001; Tucker & Oei, 2007).  
Concerns over negative interpersonal traits may contribute to many people not 
being considered for group treatment, as those assessing for treatment might 
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have concerns about group dynamics or a person being able to tolerate a 
group (Constantino et al., 2008; Constantino et al., 2012; Leader & Klein, 
1996). Group treatment for PDD includes evidence from CBASP which is 
tailored to deal with these issues (Sayegh et al., 2012; Locke et al., 2016), so 
any potential resistance or interpersonal problems (e.g. hostility or 
submissiveness) can be successfully overcome in a group environment (Locke 
et al. 2016). CBASP theory suggests that interpersonal change follows skill 
acquisition of the key skills of interpersonal learning in CBASP and that this is 
what leads to decrease in depressive symptoms; it is possible this could be 
maximised by peer connections in a group environment (McCullough et al., 
2020) and this also fits with the theory of Yalom & Leszcz (2005). Nonetheless, 
group interventions are not tailored to the individual, and group dynamic 
problems can indeed disrupt progress in therapy while some may have 
difficulties disclosing personal information in front of others (Morrison, 2001; 
Tucker, 2007). 
 
There was mixed evidence for group and individual treatment compared with 
active treatments (other therapy and medication) for PDD, with a small non-
significant effect in group. However, a large proportion of the studies in this 
subgroup were treatment for dysthymia and this fits with Cuijpers et al. (2010) 
findings that suggest dysthymia is less receptive to psychotherapy treatment 
and might benefit more from medication. Dysthymia studies appeared to have 
a different effect and it is possible that different mechanisms in the 
development of dysthymia at play link to neurotic or anxiety co-morbidity 
(Hidalgo et al., 2012; Klein et al., 2000; Rhebergen & Graham, 2013).  
 
1.5.3 Strengths and Limitations 
This study collates the current available evidence comparing group and 
individual treatment for PDD and gives tentative results that there could be an 
advantage for group psychotherapy for PDD over individual psychotherapy. 
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Yet, the preliminary findings should be considered with care as this study does 
have several limitations. The conceptualisation of chronic depression and 
dysthymia has been chosen with the specified criteria from DSM-5 but other 
studies may categorise it differently or include terms such as TRD. While the 
studies were checked that they met the criteria for PDD it was often not clear 
in the research papers and some studies may have been discarded 
unnecessarily. Two studies which were outliers used the self-report BDI-II 
instead of the therapist measured HRSD-17, and it is possible that bias could 
affect either measure and this should be controlled for. 
 
This meta-analysis found a broad mixture of treatments for PDD. 
Unfortunately, there were too few samples to be able to compare types of 
treatment by group and individual therapy, and it would be useful to know 
which therapies used an interpersonal element as recommended (Jobst et al., 
2015) as they may have an added an advantage. Interpersonal behaviours 
such as hostility and submissiveness are not addressed in some therapies for 
PDD like IPT while CBASP addresses them directly (Schramm et al., 2015) 
and assessing such moderators and mediators of change would be beneficial. 
Likewise, it was not possible to explore further moderators such as type of 
control condition. The dose of therapy is another important feature in the 
literature and with only a third of the 20 studies reaching the recommended 18 
sessions; understanding the impact of number of sessions as a moderator was 
not addressed in this study (Cuijpers et al., 2010; Schramm et al., 2019).   
 
Due to the lack of follow up information available it was not possible to look at 
long term effect or remissions rates by group or individual therapy. Indeed, 
dropout was not considered in this study. With rates of support for people with 
depression already low (Wang et al., 2007), combined with treatment 
resistance and higher dropout rates in PDD (DeCarlo et al., 2016; Keller et al., 
2014) this is another limitation of this meta-analysis. Unfortunately, many of 
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the studies were of poor quality and half were at an overall high risk of bias. 
Studies had a lack of clarity in reporting protocols, the randomisation process, 
and with issues such as missing outcome data, and selective reporting. These 
areas must be addressed to ensure research findings are rigorous and robust 
with minimal bias. The studies are in the main from Europe and the US and 
therefore, may not be generalisable out-with this area. Conversely, the 
contextual differences of the studies are wide ranging from type of therapy, 
recruitment of participants (clinical, outpatient, inpatient), to number of 
sessions offered. This raises the question if these differences are so significant 
that the studies might not be meaningful compared. Additionally, it could be 
argued that in comparing treatments for PDD and separating by mode of 
delivery the high heterogeneity means the meta-analysis could be comparing 
two completely different things; however, the exploratory nature of this study 
is thought to be useful to survey the evidence and possibly highlight directions 
for further research in this field (Field, 2005). Although the analysis did not 
indicate publication bias there was not a rigorous screening of the grey 
literature and since 12 studies could not be used due to insufficient information 
there was a third of studies missing at least. Indeed, the issue of “file drawer” 
(Field, 2005) where studies do not get published unless they have a positive 
result may mean any evidence of effect should be taken with extreme caution. 
 
1.5.4 Future research considerations 
This meta-analysis demonstrated an advantage in favour of group 
psychological therapy over individual therapy for PDD. However, the review 
also highlights the limitations of the evidence base and the need for further 
high-quality research. This would allow comparisons of different types of group 
interventions and controls that were not possible here. Attention should be 
directed to exploring the differences in the response of dysthymia and 
understanding the patient group better. Additional focus on length of treatment 
and follow up is important to make sure any change in depression is 
maintained long term. The majority of studies in this meta-analysis used the 
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HDRS-17 or BDI-II depression measures and since rates of anti-depressant 
use is climbing with associated risks of side effects and withdrawal symptoms 
that are linked to these questionnaires, the impact of any effect of using these 
measures is not known but should be considered in future studies (Hieronymus 
et al., 2021; Kendrick et al., 2021; NHS Digital, 2019; Saha et al., 2021). 
Research is required to understand the mechanisms of treatment for PDD in a 
more comprehensive way. This should include the impact that interpersonal 
variables have, for instance, measuring the specific interpersonal process of 
change that may be facilitated by group interactions and environments. It is 
hoped this could help conceptualise the apparent differences in treatment 
efficacy for dysthymia and allow for fine tuning or personalised treatment for 
those with PDD by taking into account moderators (such as childhood 
maltreatment, early or late onset, interpersonal traits). Lastly, it is important 
that studies also examine the efficacy of the implementation of RCT’s into 
clinical practice to improve the provision for those who have PDD and ensure 
they get the ongoing evidence-based support that is recommended (Arnow & 
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Chronic/persistent depression is a debilitating condition which can be difficult 
to treat. Cognitive Behavioural Analysis System of Psychotherapy (CBASP) is 
a psychological treatment for persistent depression which has a solid evidence 
base. Little is known about the mechanism of change during CBASP. It is 
hypothesised that as learning acquisition increases in CBASP participants 
symptoms will improve.  
 
2.1.2 Methods 
To test out this hypothesis clinical outcome data from 13 groups of CBASP 
(CBASP-G) were analysed using multi-level modelling statistical methods and 
paired t-tests. Outcome data from 80 participants who attended CBASP-G for 
persistent depression between 2011 and 2021 in an outpatient primary care 
setting were entered into SPSS. Multi-level models were built to look for any 
pattern between skill acquisition in CBASP-G and weekly change in reported 
Mood and CORE-10 score. Paired t-tests were run to look at overall change in 
outcome data for BDI-II, CORE-10, Mood, IIP-32, PGI, CGI-I and CGI-S. 
Multiple imputation was used to deal with missing data for the t-tests. 
 
2.1.3 Results 
Paired t-tests and exact sign tests demonstrated that CBASP-G significantly 
improved depression (BDI-II t(25)=4.181, p<0.001, d=0.820), distress 
(CORE—10 t(29)=3.034, p=0.005, d=0.554), mood (t (35)=-3.768, p=0.001, 
d=-0.628, and global indicators of improvement scores. Changes in total IIP-
32 were not significant but there was significant change in the hostile-
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submissive domain (t(25)=3.433, p=0.002, d=0.673). Multiple imputation 
upheld the core findings of the t-tests. Multilevel models suggested that the 
change in distress and mood scores were linear during CBASP-G, that there 
was no regression to the mean over time pointing to an effect of therapy. 
Measures of skill acquisition (PQ-SA, PQ-IDE, PPRF) all improved the model 
fit significantly indicating they are important to an improvement in symptoms. 
However, only the fixed effect of PQ-SA for the CORE-10 model was 
significant and the PQ-SA*Time for the Mood model. Skill acquisition was 
quadratic in nature, with competency increasing at the start of therapy and then 
levelling off. The group attended may have had a small effect on the outcome 
for the CORE-10, however, there was not enough data to model the effect of 
the group for the mood scores.  
 
2.1.4 Conclusions 
CBASP-G in an outpatient setting had an effect in reducing depression and 
overall distress and increasing mood over the 20-week sessions; this is in line 
with previous research. Skill acquisition in CBASP-G is important to explaining 
the variance in symptoms, however, perhaps due to the small sample only PQ-
SA was significant. Interpersonal change was present for hostile-submissive 
traits. There was a substantial amount of outcome data missing from this 
sample and there may be a lack of power to find proposed effects in IIP change 
and a link between skill acquisition over time. This study highlights that 
CBASP-G in practice in outpatient setting is effective and supports that the key 
learning acquisition of the situational analysis in CBASP is an important part 
of improving symptoms and interpersonal style. 
 
Keywords: Chronic depression, Persistent Depressive Disorder, Multilevel 
Modelling, CBASP, skill acquisition. 
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2.2 Original research 
 
2.2.1 Introduction 
Most people will experience a mental health condition across their lifespan and 
the two most common are anxiety and depressive disorders (Caspi & Moffitt, 
2020; World Health Organisation (WHO), 2020). Depression is the biggest 
reason for disability worldwide, can lead to suicide and its economic and social 
burden has made it a global health challenge (Hewlett et al., 2014; Wittchen et 
al., 2011; WHO, 2020). The Scottish Health Survey (2019) estimates that 
around 12% of people in Scotland report at least two symptoms of depression. 
More recently, in the first months of 2021 it is estimated that around 21% of 
adults across the UK report symptoms of depression (moderate to severe 
assessed by PHQ-8), almost twice the pre-COVID-19 pandemic level of 10% 
(ONS, 2021). Additionally, people with depression use 1.5 to 2 times health 
service resource than those without (Arnow & Constantino, 2003). 
 
Chronic or persistent depression is classified as having depressive symptoms 
present for at least 2 years; the Diagnostic and Statistical Manual of Mental 
Disorders 5th edition (DSM-5) reclassified the four subtypes of chronic 
depression (chronic depression, dysthymia, double depression, recurrent 
depression without full remission) to an overarching persistent depressive 
disorder (PDD) which can be early or late onset (before or after age 21) 
(American Psychiatric Association, 2013). Around 30% of those with 
depression are thought to have PDD (Murphy & Byrne, 2012; Rubio et al., 
2011). The International Classification of Diseases 11th revision (ICD-11) use 
a coding system to define the persistent element of MDD and use similar 
definitions of 2 years without remission (World Health Organization, 2018).  
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Persistent depression places a huge burden on strained health services, using 
a disproportionate amount of mental health services (Torpey & Klein, 2008). 
Indeed, the effect on the individual and those around them can be substantial 
with those with PDD having higher co-morbidity for mental health and medical 
problems and lower quality of life than those with episodic depression (Angst 
et al., 2008; Gilmer et al., 2005; Murphy & Byrne, 2012; Pettit et al., 2008). 
Additionally, there are delays and variability in people getting sufficient 
treatment for PDD and poorer outcomes from treatment than non-chronic 
depression (Jobst et al., 2015; Pettit et al., 2008; Rubio et al., 2011).  
 
Cognitive Behavioural Analysis System of Psychotherapy (CBASP) is the only 
type of therapy that has been specifically designed to treat PDD through 
facilitating interpersonal change (McCullough, 2020). This paper will use data 
from participants with PDD who attended a group version of CBASP (CBASP-
G) to examine the change processes and effectiveness of this group 
intervention. Moderating factors, limitations and directions for future research 
will be discussed. 
 
2.2.2 Mechanisms in PDD 
Research has attempted to explain likely contributors and mechanisms 
involved in the development and maintenance of chronic forms of depression 
but issues such as the classification of PDD and a lack of understanding of the 
course of depression across the lifespan have complicated the matter. (Neubel 
et al., 2020; Rhebergen & Graham, 2014). 
 
2.2.2.1 Childhood maltreatment 
There is evidence that childhood maltreatment (CM) 
(emotional/physical/sexual abuse, neglect) is a feature in the development of 
PDD (Cicchetti & Barnett, 1991; Klein et al., 2015; Nelson et al., 2017), with 
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around 65% of those with PDD having a history of CM (Wiersma et al., 2009). 
Furthermore, CM is linked to an earlier onset of depression, an increase in 
severity and chronicity of depression, and co-morbidity with other disorders 
(Nelson et al., 2017; Wiersma et al., 2009). Neglect and emotional abuse are 
thought to inhibit adaptive coping strategies developing, characterised by the 
“preoperational” cognitive development stage between the ages of 4 and 7 
causing poor emotional control and a lower ability to tolerate distress 
(McCullough, 2000; Piaget, 1981). Research supports these factors are more 
commonly found in individuals with PDD than MDD (Barnhofer et al., 2014; 
Bird et al., 2018; Domes et al., 2016). McCullough (2000) suggests this 
happens through the triggering of early memories of shame and link to the 
development of dysfunctional cognitive patterns (Klein et al., 2009). Indeed, 
Guhn et al. (2018) found that autobiographical memories of difficult 
interpersonal experiences could be a factor in triggering dysfunctional coping 
in chronic depression. However, it is a mixed picture with recent reviews finding 
inconsistent support for CM being a moderating factor between chronic and 
non-chronic forms of depression (Köhler et al., 2019; Szpak, 2020). 
Furthermore, evidence suggests that CM could be a factor in reducing or 
stopping the response from psychotherapy (Baush et al., 2017; Nanni et al., 
2012) implying there could be other more salient moderators in PDD. 
  
2.2.2.2 Interpersonal difficulties 
Findings suggest that interpersonal problems are an important aspect in the 
development and maintenance of depression, and it has been proposed that 
this is more pronounced in PDD (Leader & Klein, 1996; Bird et al., 2018). 
Interpersonal factors of hostility and submissiveness, as measured by the 
Interpersonal Inventory (IIP-32), were found to be linked to PDD (Constantino 
et al., 2008) while Constantino et al. (2012) found that the reduction in Hostile-
Submissive interpersonal style was significantly related to decrease in 
depression scores through the clinician rated Impact Message Inventory (IMI). 
Two meta-analyses have found support for submissive and hostile 
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interpersonal styles as being a common factor for those with PDD (Bird et al., 
2018; Köhler et al., 2019). Hostile, submissive and hostile-submissive (socially 
avoidant) interpersonal styles (Appendix C.) were found to be more 
pronounced in individuals with chronic depression compared with major 
depressive disorder (MDD) (Bird et al., 2018). However, these findings are 
tentative as research in this area is limited with few studies directly comparing 
chronic depression and MDD, and the quality of studies that do exist is poor 
(Bird et al., 2018).  
 
2.2.3 Treating persistent depression 
Treating early-onset PDD is thought to be challenging due to deep seated 
avoidance patterns in relating, which have been fostered by difficult childhood 
experiences resulting in ingrained unhelpful thoughts, feelings and behaviours 
(McCullough, 2020). Psychological interventions that have an evidence base 
for treating severe or persistent depression include CBT, Inter-personal 
psychotherapy (IPT), behavioural activation, and Cognitive Behavioural 
Analysis System of Psychotherapy (CBASP). These can be complemented 
with anti-depressant medication (The Matrix, 2015; National Institute for Health 
and Clinical Excellence (NICE), 2017). The European Psychiatric Association 
Guidance (EPAG) recommends combined treatment of pharmacotherapy and 
psychotherapy, with an interpersonal approach for the therapy (Jobst et al., 
2015). 
 
Anti-depressant medications (serotonin reuptake inhibitors (SRI’s)) are 
routinely used in the treatment of depression, however, the rates of efficacy 
and remission using anti-depressants are unsatisfactory – in chronically 
depressed patients it is less than 30% (Ijaz et al., 2018; Krystal et al., 2011; 
Trivedi et al., 2006). Furthermore, issues with tolerating medication, common 
side effects and withdrawal are common, and this is made more difficult by the 
lack of appropriate alternative options such as therapy to support continued 
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improvement of depression symptoms and prevent relapse (Arnow et al., 
2003; Kendrick, 2021; Saha et al., 2021). Some side effects of medication 
(e.g., sleep problems, sexual issues, eating) are questions on the depression 
questionnaires (BDI-II etc.) and may interfere with the true picture of 
depression symptoms (Hieronymus et al., 2021). Of note, a recent analysis of 
the Combining Medications to Enhance Depression Outcomes (CO-MED) trial 
found that those with PDD and CM did not respond differently to medication 
than those without CM, but the burden of side effects was more pronounced 
(Medeiros et al., 2021). Patient preference for psychological therapy has been 
demonstrated in McHugh et al. (2013) meta-analysis and meeting patient’s 
choice for treatment has been shown to be a factor which can improve efficacy 
and reduce drop-out from treatment (Mergl et al., 2011; Swift et al., 2011; 
Williams et al., 2016). 
 
Reduced social support may be a predisposing factor for the development of 
depression and can increase the likelihood of dropout from therapy due to 
lessened ability to navigate social functioning (Keller et al., 2014). Patient’s 
with PDD often have co-morbid Axis I and II disorders, combined with traumatic 
childhoods, and may feel worthless and hopeless. This can make the 
therapeutic relationship challenging with the possibility of countertransference 
and strong emotional reactions, and in some cases a rupture or 
disengagement could happen (Klein & Santiago, 2003; McCullough, 2020). 
However, the evidence for treating PDD comes from clinical trials which often 
lack ecological validity, for example, in recruitment and by excluding 
participants with co-morbid disorders, and in reality, clinical practice is very 
different (Trivedi et al., 2006).  
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2.2.3.1 Cognitive Behavioural Analysis System of Psychotherapy 
(CBASP)  
CBASP is the only model of psychotherapy specifically designed to treat PDD, 
and it aims to teach individuals to understand and modify their unhelpful 
contributions in interpersonal situations for a more positive or beneficial 
interaction (McCullough, 2020). It utilises cognitive, behavioural, 
psychodynamic and interpersonal techniques facilitated by a therapist who 
uses their own relationship with the person to model and facilitate change 
(McCullough, 2003). The model proposes that chronic depression is triggered 
by poor relational expectations due to CM and the persons interpersonal 
response isolates and maintains the depression leading to it developing early 
and becoming chronic (McCullough, 2000). McCullough (2020) depicts the 
patient with early on-set PDD as functioning with “cognitive-emotional maturity 
level of a 4–6-year-old child” (McCullough, 2020, p3). 
 
2.2.3.1.1 Evidence base for CBASP 
CBASP has a good evidence base for treating chronic depression (Furukawa 
et al., 2018; Keller et al., 2000; Kriston et al., 2014; Negt et al., 2016; Schramm 
et al., 2011; Wiersma et al., 2014) and is a recommended treatment for PDD 
in Europe and the United Kingdom (Jobst et al., 2015, The Matrix, 2015; NICE, 
2017) though it is not commonly available in routine services (Schramm et al. 
2017). CBASP was found to be moderately more efficacious than non-specific 
psychotherapy in an RCT of patients suffering from early-onset chronic 
depression, with remission rates of over 36% (Schramm et al. 2017). A re-
analysis of this data has found that patients with moderate to severe 
depression and CM were more likely to respond to CBASP while those with 
less severe symptoms, better social functioning and quality of life responded 
better to supportive psychotherapy, giving some support to McCullough’s 
(2003) theory of CM affecting interpersonal functioning (Serbanescu et al., 
2020). However, this study may lack ecological validity as it only selected 
patients who were not on anti-depressant medication not reflecting the reality 
of everyday outpatient experience.  
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A recent analysis using individual patient data found evidence that a 
combination of anti-depressant medication and CBASP was more effective 
than either treatment alone with less likelihood of drop out from treatment 
(Furukawa et al. 2018). Using patient characteristics, it is suggested that 
treatment can be tailored for individuals, for instance co-morbid symptoms may 
mean CBASP alone is more suitable (Furukawa et al. 2018). However, a 
longer term follow up of CBASP suggests that for early-onset PDD patients 32 
sessions over 48 weeks may not be enough dose for a long-term reduction of 
symptoms, with only 50% achieving remission after two years (Schramm et al., 
2019). This adds weight to the need for offering booster sessions and ongoing 
maintenance, as McCullough (2020) highlights that change needs support to 
be maintained as the skills learnt fade over time. A re-analysis using multilevel 
modelling of Michalak et al. (2015) study comparing Mindfulness Based 
cognitive therapy (MBCT) and CBASP group therapy suggested that MBCT 
was more advantageous for “vindictive/self-centred/hostile dominant” 
interpersonal type while CBASP was better for “non-assertive” in treating 
chronically depressed individuals (Probst et al., 2020). 
 
2.2.3.1.2 Support for key factors in CBASP treatment 
Vivian & Salwen (2013) summarised the components of CBASP treatment and 
highlighted some evidence for its theoretical underpinnings. They compare the 
Situational Analysis (SA), in which behaviour is the main aspect linking 
thoughts and feelings to outcomes, to functional analysis which is used in 
Beck’s (1987) CBT therapy (Paykel, 1987) with main difference being 
achieving the desired outcome is the goal for change. Santiago et al. (2005) 
found evidence to suggest that the SA process of problem-solving real 
situations was linked to better outcomes, even when the effect of therapeutic 
relationship was accounted for, and Klein et al. (2011) found improvement in 
interpersonal problem solving led to decrease in depression symptoms. 
Furthermore, there have been indications that learning SA techniques online 
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can have a preventative effect on the development of anxiety and depression 
in a sample of college students (Cukrowicz et al., 2007). 
 
Improvements in depression symptoms are proposed to happen through 
interpersonal change. Inpatients receiving 12 weeks of CBASP were found to 
have reduction in interpersonal distress that was significantly linked to a 
decrease in depression symptoms, however, this was a naturalistic study with 
no control groups (Guhn et al., 2021a). Klein et al. (2020) recently used 
sequential mediation to re-examine Schramm et al. (2017) CBASP advantage 
over SP and linked it to improvement in therapeutic relationship due to the 
reduction in the IIP measure of Hostile-submissive. Blalock et al. (2008) found 
CBASP reduced depression symptoms through change in escape-avoidance 
coping style.  
 
Research has pointed to the added benefits of group therapy including 
supporting interpersonal improvement, positive peer interaction, shared 
learning and modelling (Lewinsohn & Clarke, 1999, Morrison, 2001) and group 
CBT for depression has been found to be as acceptable and efficacious as 
individual therapy (Cuijpers et al., 2019). Group CBASP has been established 
to be as effective as individual therapy and can deliver some additional 
advantages such as cost effectiveness, opportunities for social connection, 
practice interpersonal change to improve social functionality leading to a 
decrease in interpersonal problems (Locke et al., 2016; Michalak et al., 2015; 
Sayegh et al., 2012; Saba et al., 2018). However, not a great deal is known 
about the factors that mediate the effect specifically in group CBASP and it is 
important that group therapies are developed and evaluated to maximise utility 
and cost-effectiveness (Guhn et al., 2021b; Sayegh et al., 2012). Even more 
so as there can be problems with research evidence being operationalised into 
clinical practice with protocols not being followed and recommended 
maintenance therapy not being offered (Schindler et al., 2011; Riihimaki et al., 
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2017). Qualitative information gathered from a recent study of inpatients with 
PDD receiving 24 weeks of individual and group therapy found patients self-
reported improvements following CBASP were “increased social competence, 
self-confidence, self-reflection, interpersonal dynamic and optimism” (Guhn et 
al., 2021b, p.9). Furthermore, there was a slight advantage with group therapy 
over individual CBASP but this could be attributed to the higher “dose” of group 
element adding benefit and unspecific benefits of group treatment are also not 
understood (Guhn et al., 2021b). 
 
2.2.3.1.3 Learning and skill acquisition in CBASP 
There is a lack of understanding of what parts of therapy works best for PDD 
and why, with research on single moderators often giving contradictory results 
with very small effects, and confounding factors difficult to prise apart (Jobst et 
al., 2015; Kraemer, 2013). The mechanisms of change in group CBASP are 
not fully known, though it is suggested that learning acquisition precedes 
change in symptoms, and this is a unique part of CBASP (McCullough, 2020). 
McCullough (2000) theorises that by achieving the learning objectives in 
CBASP through the tasks, such as the SA, the patient would move from the 
pre-operational to the formal operations thinking and that this would lead to 
better relationships and reduce depressive symptoms and distress. Evidence 
has shown that outcomes tend to improve after the core phase of treatment for 
chronic depression is complete and this supports longer input and a 
maintenance phase approach (Arnow & Constantino, 2003). 
 
A measure of skill acquisition (the Patient Performance Rating Scale (PPRF)) 
is used to assess a patient’s ability to successfully complete SA. Manber et al. 
(2003) found PPRF success at midpoint in therapy predicted a positive 
outcome in CBASP and that medication did not mediate this result. Moreover, 
Santiago et al. (2005) found that therapeutic alliance and PPRF scores were 
small and individual predictors of improvement in depression symptoms during 
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CBASP treatment. These findings suggests that medication is adding to any 
positive effect separately and not facilitating the interaction with the skill 
acquisition leading to change (Manber et al., 2003; Santiago et al., 2005). 
However, there are issues with the PPRF as a measure as it is therapist rated 
and may bring bias into scoring and an independent rating system would avoid 
that (Manber et al., 2003). Santiago et al. (2005) suggest growth curve 
analyses could help explore relationships between skill acquisition and 
depression outcome over time 
 
 
Figure 7. McCullough’s (2020) “CBASP acquisition learning and symptoms 
assumption curves shown in a hypothetical design space”. 
 
The change in learning acquisition during CBASP is captured through two 
measures: The Personal Questionnaire – Situation Analysis (PQ-SA) and The 
Personal Questionnaire – Interpersonal Discrimination Exercise (PQ-IDE). 
McCullough (2020) described the change as the ability to achieve skills as 
measured by the PQ-SA and PQ-IDE increasing over time, while the 
depression symptoms decrease over time (Figure 7). Bird (2016) found in an 
analysis of Swan et al.’s (2013) single case series data a linear change in 
symptoms from individual CBASP.  
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The PQ-SA captures the patient’s understanding of their interpersonal 
functioning (“perceived functionality”), and hostile and submissive personality 
traits, which were potentially adaptive when a person was experiencing CM, 
impinge on the development of meaningful relationships (McCullough et al., 
2000). The PQ-SA measures the patient’s understanding of the impact that 
their behaviour has on situations and desired outcomes (Bird et al., 2018; 
Köhler et al., 2019). The Personal Questionnaire – Interpersonal 
Discrimination Exercise (PQ-IDE) which measures feelings of interpersonal 
safeness in discriminating the therapist from significant others (“dyadic safety”) 
(McCullough, 2020).  The impact of CM, which is often interpersonal trauma, 
leads to poor emotional control, maladaptive coping and shame based 
dysfunctional thinking patterns (Barnhofer et al., 2014; Domes et al., 2016; 
Guhn et al., 2018; Klein et al., 2009; McCullough, 2000); this prevents the 
person feeling safe in interpersonal situations and the IDE process of 
supporting the person to discriminate the therapist, and then others out-with 
the sessions is the process of change. Being stuck in pre-operational thinking 
does not allow the patient to generalise previous positive interpersonal 
situations and the CBASP therapy environment cultivates and encourages this 
change to formal operations thinking (McCullough, 2000; Piaget, 1981).  
 
2.2.4 Current study 
With issues of implementing RCT’s into clinical practice and added advantages 
of groups it is important to evaluate the efficacy and change processes in group 
treatment for PDD (Morrison, 2001; Riihimaki et al., 2017). Due to the COVID-
19 pandemic restrictions prohibiting the ability to carry out novel research, a 
secondary dataset was sourced and utilised. A range of data was collected 
routinely by practitioners as part of CBASP treatment. The data was intended 
to be used to evaluate the efficacy of the intervention. The current study aimed 
to explore the process of change in a sample of persistently depressed patients 
who attended group CBASP in the community, by investigating if skill 
acquisition in CBASP was linked to a change in overall distress (CORE-10) 
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and self-rated Mood score. Those attending the group would be likely to have 
experienced CM, have reduced interpersonal functioning, and present with 
hostile and submissive traits (Barnhofer et al., 2014; Bird et al., 2018; Domes 
et al., 2016; Guhn et al., 2018; Klein et al., 2009; McCullough, 2000). Based 
on McCullough’s (2000) theory of skill acquisition causing interpersonal 
change which leads to positive outcomes, it was hypothesised that any change 
in symptoms would occur later in therapy as this unfolds. As the patient learns 
the effect their behaviour has on impacting interpersonal situations by doing 
the SA, they try changing their behaviour and this would lead to improved 
functioning (as measured by the PQ-SA) and then reduced symptoms. 
Learning in the IDE would be hypothesised to change as a person feels safer 
in interpersonal situations, following from learning to discriminate the therapist 
from the SO, and applying this to other situations outside therapy, leading to 
improved discrimination (measured by PQ-IDE) and change in symptoms. As 
the thinking moves from pre-operational to formal operations thinking 
(McCullough, 2000; Piaget, 1981) the learning would be generalised. Change 
was investigated by fitting a multilevel model to the participants data to 
examine if it is linear or non-linear in nature. Measures of skill acquisition (PQ-
SA, PQ-IDE, PPRF) were added to the model to explore their relationship to 
symptoms change. Furthermore, change in interpersonal functioning was 
reviewed using the IIP-32 with an expectation that there would be 
improvements in hostile/submissive domains. It is thought that the group 
element of CBASP might offer an advantage to individual therapy by facilitating 
interpersonal change through positive peer interaction, group role play and 
modelling (Guhn et al., 2021b; Locke et al., 2016; Sayegh et al., 2012). 
 
It was predicted that there would be an increase in measures of learning 
acquisition of CBASP skills (PQ-SA, PQ-IDE, PPRF) that precedes the 
reduction of distress and depression symptoms over the time of the group and 
that this change will be non-linear (McCullough, 2000). In addition, it was 
thought that there would be a decrease in depression symptoms, overall 
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distress, and an increase in mood scores over the group. It was expected that 
patients and therapist would report global differences in symptoms. Change in 




Ethical approval was granted by the University of Edinburgh and Caldicott. 




Individuals experiencing long-term depression symptoms were offered a 
CBASP group as treatment after being assessed in a psychological therapies 
primary care service in the UK. Eighty-six people opted in and were assigned 
to thirteen groups which ran consecutively from 2011 to 2021. Baseline and 
outcome data was collected routinely in the service. This study was registered 
with Open Science Framework (OSF) ( osf.io/4cthz). 
 
2.3.2 Measures 
Routine measures were collected throughout and are detailed below: 
Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM) 
(Evans et al., 2002) and Clinical Outcomes in Routine Evaluation 10 
(CORE-10) (Barkham et al., 2013).  A self-report measure of overall 
psychological distress, including anxiety, depression, trauma and risk 
questions, giving a score out of 40. This measure has good reliability, validity 
and is sensitive to change. 
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Beck Depression Inventory – Second Edition (BDI-II) (Beck et al., 1996). A 
self-report 21 item measure of depression, using score or 0-3 to measure 
occurrence and severity of symptoms. It is reliable and valid with good internal 
consistency (Beck et al., 1996). 
Inventory of Interpersonal Problems – 32 (IIP-32) (Horowitz et al., 2000). A 
32 item self-report measure to examine interpersonal issues and related 
distress. It has eight scales with good agreement and is sensitive to measuring 
change. 
Patient Global Impression - Improvement scale (PGI), Clinical Global 
Impression – Improvement (CGI-I) and Clinical Global Impressions – 
Severity (CGI-S) (Guy, 1976). These are general measures of severity and 
treatment response commonly used in UK primary care mental health 
services. PGI is a 7-point scale (1= very much improved, 7 = very much worse) 
of patient rated global functioning. CGI-I is the clinician rated improvement 
score on the same scale. The CGI-S is the clinician rated severity scale (1 = 
Normal, not at all ill to 7 = Among the most extremely ill patients). These 
measures are valid for use for patients with major depression with 
concordance between PGI and CGI (Mohebbi et al., 2018). 
Specific CBASP measures collected in line with CBASP manual guidelines 
during the therapy sessions (McCullough, 2006). They include: 
Personal Questionnaire – Situation Analysis (PQ-SA) (McCullough, 2006).  
This is used to measure interpersonal perceived functionality and was 
collected at 5 points during therapy. 
Personal Questionnaire – Interpersonal Discrimination Exercise (PQ-
IDE) (McCullough, 2006). This is used to measure emotional discrimination 
learning and was collected 5 times over therapy in line with the CBASP manual 
guidelines. 
Patient Performance Rating Scale (PPRF) (McCullough, 2000). The 
CBASP-G PPRF was adapted from the McCullough (2000) manual to 10 
 
Effectiveness and change processes in CBASP-G for PDD.
  74 
questions and is used to measure the client’s competence at completing the 
situational analysis sections. 
Additionally, a Mood score out of ten (ten being the best mood, one being the 
lowest) was taken every week at the start of the group for each participant as 
a measure of what their average mood was in the past week. 
 
2.3.3 Procedure 
Following an initial assessment at a psychological therapies service, patients 
deemed suitable with PDD symptoms were invited to attend a CBASP group. 
After opting in, each person attended three individual sessions with one of the 
therapists from the group. At these sessions baseline measures were 
completed (BDI-II, IIP-32, CORE-10). In addition, the Significant Other History 
(SOH) was completed for each patient. Each group consisted of twenty weekly 
sessions of 2 hours, and thirteen groups with 86 people invited to attend, 
running consecutively. The group followed the CBASP protocol (Appendix D.), 
and participants completed Situational Analysis (SA) and Interpersonal 
Discrimination Exercises (IDE), alongside the respective learning acquisition 
measures (PQ-SA, PQ-IDE) during the group. The PPRF was scored by the 
therapists over the course of the group by assessing the patient’s SA’s. BDI-II 
and IIP-32 were completed halfway through (week 10) and end of therapy 
(week 20). CORE-OM scores were taken at start and end of therapy in first 
three groups then weekly in groups four to thirteen. Mood scores (10 being 
best mood, 1 lowest) were taken at every week in groups two to thirteen. PGI, 
CGI-S and CGI-I were taken weekly from group five to thirteen. 
 
2.3.4 CBASP-G Intervention 
The group version of CBASP (CBASP-G) was developed to follow the core 
principles of individualised CBASP. Dr James P. McCullough, Jr developed 
CBASP spurred by his reflections of his clinical experience of working with 
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long-term depressed patients, who did not respond as well to traditional 
treatments such as CBT (McCullough, 2000). The theory underlying CBASP 
suggests that children who experience maltreatment may develop adaptive 
ways of coping (e.g., avoiding the threat or being submissive) and result in an 
expectation that other relationships will be the same, which would maintain 
fear and avoidance in interpersonal interactions. McCullough (2000) states 
that these early experiences leave the person “like a wounded child” in their 
adult relationships where they expect others to cause them harm if given the 
chance. McCullough (2000) links this difficulty in chronically depressed 
individual’s to being emotionally “stuck” in Piaget’s (1981) “pre-operational” 
stage of development (Piaget, 1981). The expectation that others will have bad 
intentions (like the significant other that maltreated) makes it hard for the 
individual to build trusting relationships. This could result in early onset 
depression which is typical of those with chronic types of depression 
(McCullough, 2000). In late onset chronic forms of depression people are 
theorised to have a deterioration in cognitive emotional functioning due to a 
significant negative event that leaves the person helpless and hopeless about 
their situation improving (McCullough, 2000). 
 
The CBASP model uses cognitive, behavioural and interpersonal techniques 
to allow the patient to reflect on how they interact with others and try doing 
things differently to aim to get their needs met. The process in CBASP of 
examining unhelpful interpersonal patterns and actively working to foster 
adjustment in interpersonal situations is theorised to offer change in 
interpersonal approach and reduce depression. This is facilitated by the 
therapist who uses a Disciplined Personal Involvement (DPI) approach to 
model and encourage interpersonal change (McCullough, 2003). This is 
traditionally a highly unusual role for therapists to take as in CBASP they use 
their personal feelings and thoughts in a specific and controlled manner to 
expedite change in the patient, and such personal input is usually forbidden in 
other therapy modalities (McCullough, 2006 & 2020). McCullough (2020) 
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states that PDD is a “lifetime disorder” that can be managed by practicing 
CBASP skills and maintenance support can ensure this is continued. 
 
Patients attended three individual sessions with a group therapist to collect 
baseline measures, complete a timeline, and develop a Significant Other 
History (SOH), which involves identifying key people who have influenced how 
they think and behave and interact interpersonally, and reveals key 
interpersonal fears (McCullough, 2020). From the SOH a transference 
hypothesis (TH) was created to help conceptualise the predicted fearful 
expectations of how others in the group and the therapists will react negatively 
towards them (McCullough et al., 2006).  The group element of the intervention 
is run from the CBASP-G protocol (Appendix D.). The first session consists of 
psychoeducation around persistent depression and CBASP, and the setting of 
group ground rules. Each person is required to introduce themselves and give 
“hopes and fears” of coming to the group. Filling in the first PQ-SA is a task of 
the first session, and this requires the participant to mark along a line-scale of 
0 to 10 how their current thinking answers if they see a connection between 
their behaviours and how things turn out for them on a line scale from No (0) 
to Yes (10). At the second session, previous completers of CBASP-G share 
their experience, previous learning is shared (Transference Hypothesis (TH)), 
discussion about the importance of their current interpersonal relationships, 
and the Situational Analysis (SA) is introduced. PQ-IDE is filled in to measure 
in similar method to PQ-SA to measure how well the individual can discriminate 
between maltreating interpersonal relationships and therapist/group member 
using the TH.  
 
The following sessions are a combination of group exercises, discussions, role 
play using the SA as a learning tool. The SA is completed by the participant 
weekly as homework using interpersonal issues that arise, in session they are 
reviewed together and the therapists complete the PPRF after the session 
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giving a rating out of 100% of how well the learning in the SA has been 
demonstrated. At each weekly session the group members fill out CORE-10, 
PGI, and therapists fill in the CGI-I and CGI-S, and a self-reported Mood rating 
is taken. The PQ-SA is completed at groups 5, 9, 13 and 17 and the PQ-IDE 
at 7, 11, 15, and 19. The question in the PQ-IDE was changed in Group 8 from 
discriminating others in group from SO to adding a rating of others more 
generally. An interpersonal discrimination exercise (IDE) is introduced at 
session 10 to work on a situation which the recalled behaviours of a SO 
maladaptive interpersonal relationship can be contrasted with how the 
therapist responds to the same situation. The IDE therapy procedure takes 
place throughout group therapy when the opportunity arises, and the PQ-IDE 
and PQ-SA are collected regularly to assess learning acquisition of the skills. 
The main content of CBASP-G is the evaluation of the SA and IDE homework 
and using that to inform role-play, discussions and exercises to facilitate 
interpersonal learning. 
 
2.3.5 Data preparation 
Data was extracted from questionnaires into an excel file. Where more than 
one PPRF was collected for a week, the scores were averaged. Unfortunately, 
there was a sizeable amount of data missing or unavailable from the secondary 
dataset. Of the 80 participants who started treatment only 30 had CORE-10 at 
start and finish and only 26 BDI-II scores at both. This was not only due to non-
attendance – in some cases the start data was unavailable or not accessible 
to the research team. The available data that was collected weekly (CORE-10 
and Mood) was around 60% that could be used in the MLM analysis. 
 
2.3.6 Data Analysis 
Data analysis was performed using IBM SPSS for Macintosh (Version 25) 
(2017).  Since, the outcome measures were routinely collected in clinical 
practice there were multiple data points missing. Six participants who did not 
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start the group were removed from the analysis, leaving 80 participants 





Figure 8. Diagram of participant flow and data collection. 
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2.3.6.1 Paired t-tests 
Paired t-tests were carried out on the main outcome measures to examine 
overall effectiveness of the intervention (BDI (start to finish/week 20), CORE-
10 score (week 1 to week 20), Mood rating (week 1 to week 20) and IIP (start 
to week 20 total, hostile, submissive and hostile submissive) and PGI, CGI-S 
and CGI-I (week 1 to week 20)). The t-tests were run for participants that had 
data for both time points (Actual) (Table 1.) and regression imputation (Multiple 
Imputation) methods were carried out to handle the missing outcome data. 
Multiple imputation was chosen as the most appropriate way to handle the 
missing data, since it was missing at random, and t-tests were re-run with data 
imputed by this method (Jakobsen et al., 2017). 
 
2.3.6.2 Multi-level Modelling 
A Multi-level modelling statistical method (MLM) was selected to investigate 
patterns of change in Mood and CORE-10 score and if change was linked to 
the acquisition of learning CBASP skills. There were three levels of data:  
weekly scores at time points (Level 1), which are nested in individuals (Level 
2) and they are nested in the group that was attended (Level 3) (Field, 2013). 
MLM is advantageous as it can model variance of regression slopes, can 
model relationships between residuals and due to the nature of this real-life 
clinical data sample it can maximise the data as MLM does not require 
complete data sets and can handle missing data well (Field, 2013). 
 
The weekly collected data included CORE-10, Mood rating, PPRF score, PGI, 
CGI-I and CGI-S. This data was restructured to time point for analysis in SPSS 
and initially visually checked for equality of variance. Weekly data collection 
for CORE-10 was not started until Group 4 and the Mood ratings until Group 
2, therefore, since the missing data was not random the analysis was run for 
the Mood data Groups 2 to 13 and the CORE-10 groups 4 to 13 (Jakobsen et 
al., 2017). Data was checked to see which growth model was most suitable for 
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the dependent variable (CORE-10 and Mood); linear, quadratic and cubic 
trends were modelled. The intraclass correlation (ICC) was calculated to see 
how much variability in the outcome is attributable to each level (group, 
individual) using the calculation: ICC = (intercept variance/(intercept 
variance/residual)) (Field, 2013). The -2 Restricted Log Likelihood (-2LL) was 
checked to assess if the chi-squared difference between each model was 
significant.  
Several models were created and the data for weekly CORE-10 and Mood 
measures used: 
Model 1 – An unconditional model was set up with no predictors but allowing 
the intercept term to vary to calculate which proportion of variance is between 
participants. The covariance parameter estimates were used to calculate the 
ICC – variance between participants. 
Model 2 – Unconditional linear growth model was set up with the time-point 
variable to fit the model for change over time for the whole sample with random 
intercepts and check the trend of scores over time. 
Model 3 – Unconditional linear growth model allowing slope variation was set 
up, by adding Time to the random effects. This was to check if people have 
different rates of change. 
Model 4 – Model of the correlation structure of within (repeated) measures 
effects which are likely to be non-independent (e.g., one measure week 1 is 
likely to be more similar to week 2 measure than week 20 measure). An 
autoregressive structure was used to model this. 
Model 4a – The model was adjusted to test for level 3 (group) effects to see if 
time was significant for each group.  
Model 5 – The model was adjusted to add in fixed effect and test for interaction 
effect, to test for change in relation to the CORE-10 or Mood change. 
Measures of learning acquisition (PPRF, PQ-SA, PQ-IDE) were added into the 
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model one at a time to attempt to explain the difference in growth and assess 






2.4.1 Sample characteristics 
The age range of participants was 20 to 64 years old and a mean (SD) of 43.02 
(10.07) years. There were 61.6% female participants (53 female to 33 male). 
Mean (SD) number of sessions attended was 13.05 (6.02). Baseline measures 
mean (SD) were CORE-10 18.90 (7.52) and BDI-II 30.86 (11.59). Drop-out 
from the group was 42.5%. 
 
2.4.2 Paired T-tests results 
Paired t-tests are reported in Table 4. 
2.4.2.1 CORE scores 
CORE-10 was compared from pre-group to week 1 and data was normally 
distributed with no outliers. The paired t-test showed that the small difference 
from CORE pre to CORE week 1 was non-significant (0.667 (1.751) 
t(5)=0.933, p=0.394 . Therefore, since there were only some CORE pre data 
which was likely not missing at random, CORE week 1 was used for analysis. 
A paired samples t-test was performed to see if there was a statistically 
significant mean difference between CORE-10 score from week 1 to week 20 
(end of group) (see Table 1.). Data are mean (standard deviation (SD)), unless 
otherwise stated. No outliers were detected as assessed by boxplot inspection. 
The assumption of normality was assessed using Shapiro-Wilk’s test 
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(p=0.262). The CBASP group elicited a statistically significant decrease in 
CORE-10 score from week 1 (19.33 (7.126) to week 20 (15.40 (7.833)) of 
3.933 (95% CI, 1.282, 6.584), t(29)=3.034, p=0.005, giving a medium effect 
size of d=0.554.  
 
2.4.2.2 Mood scores 
Mood week 1 to week 20 was compared in a paired t-test. There was normal 
distribution and no outliers in the data. Of the 36 participants who had data for 
Mood the CBASP group elicited a statistically significant increase in Mood 
score from week 1 (5.014 (1.533) to week 20 (6.278 (1.775)) of -1.264 (95% 
CI, 1.282, 6.584), t(35)= -3.768, p=0.001, giving a medium to large effect size 
of d=-0.628.  
 
2.4.2.3 BDI-II 
Of 41 people who provided a BDI-II score at the end of therapy, 12 had 
reached remission (BDI-II<10). There was a statistically significant decrease 
in BDI-II scores from the start of therapy (30.04 (10.623) to finish (19.81 
(12.737) of 10.231 (12.478) (95%CI, 5.191, 15.271), t(25)=4.181, p<0.001), 









Effectiveness and change processes in CBASP-G for PDD.
  83 
Table 3. Paired T-test scores 
 
 
2.4.2.4 IIP-32 score 
A paired samples t-test was performed to see if there was a statistically 
significant mean difference between IIP-32 total, hostile, submissive and 
hostile submissive score from start to finish. Data are mean (SD), unless 
otherwise stated. No outliers were detected as assessed by boxplot inspection. 
The assumption of normality was reached using Shapiro-Wilk’s test. The 
CBASP group elicited a non-statistically significant decrease in IIP-32 total 
score of 1.60 (95% CI, -0.22577, 3.42577), t(25)=1.805, p=0.083. Similarly, 
there was a small reduction but not reaching significance for hostile IIP score 
(p=0.118) and submissive IIP-32 score (p = 0.096). However, for hostile 
submissive IIP there was a significant reduction (t(25)=3.433, p=0.002). IIP 
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Hostile-submissive had one outlier (participant 41), which was a true value. A 
re-run of the t-test after removing the outlier saw a smaller reduction of 0.400 
(95% CI, 0.042, 0.758), t(24)=2.307, p=0.030, and the effect size dropped to 
medium d=0.461.  
 
2.4.2.5 PGI, CGI-I and CGI-S 
PGI, CGI-I and CGI-S were checked for normality and due to the categorical 
nature of the data and it potentially being skewed towards scores of 2 and 3 
(min and much improved) PGI, CGI-I and CGI-S were all not normally 
distributed (data are medians unless otherwise stated). PGI also had an outlier 
(60) but since this was a true value, this was kept in the analysis. Due to the 
spread of data not being symmetrical and there being an outlier, a non-
parametric sign-test was used. An exact sign test was used as there were 
fewer than 25 values (Laerd statistics, 2021). In total, of the 17 participants,12 
had improvements in PGI, while 5 had no difference. There was a statistically 
median decrease (improvement) in PGI (1 level) from week 1 (4) to finish (3), 
p<0.001 (Table 5.).  
 
CGI-I had 15 participants and 15 had improvements in CGI-I. There was a 
statistically median decrease (improvement) in CGI-I (2) from week 1 (4) to 
finish (2), p<0.001. CGI-S had 17 participants (data are medians unless 
otherwise stated) 15 had improvements in CGI-S and 2 had no change. There 
was a statistically median decrease (improvement) in CGI-S (2) from week 1 
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Table 4. Exact sign test scores. 
 
 
2.4.3 Multi-level modelling results 
 
2.4.3.1 Modelling the change 
Preliminary analyses were run for the CORE and Mood scores to check they 
were normally distributed. Model fit was examined using CORE scores and 
Mood scores (separately) and Time (linear), then adding quadratic (Time2) and 
cubic trend (Time3). Adding these did not improve the fit significantly so both 
CORE and Mood change are best described as linear, therefore, the 




Effectiveness and change processes in CBASP-G for PDD.
  86 
 
Figure 9. CORE-10 Linear fit 
 
Figure 10. Mood Linear fit 
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2.4.3.2 CORE and Mood Multi Level Modelling 
2.4.3.2.1 Unconditional model (Model 1) 
This model was set up and run with no predictors to allow the intercept to vary 
by participant to assess the ICC(1), or proportion of the variance which is at 
the level 2 (participant level). CORE ICC(1)=0.644 and Mood ICCI(1)=0.439 
indicating a substantial variance is attributable between participants for both. 
Furthermore, the variance term for the intercept is significantly greater than 0 
(CORE 39.230 (7.950), p<0.001, Mood 1.351 (0.265), p<0.001 (see Table 6 
and Table 7.). 
 
2.4.3.2.2 Unconditional linear growth model (Model 2)  
The time-point variable TIME was introduced to fit the model for change over 
time for the whole sample with random intercepts. Adding time into the model 
improves the fit for both CORE and Mood (-2LL reduced to 4355.738 and 
3038.194 respectively). The fixed effect of TIME is negative and highly 
significant for CORE (-0.1823 (0.059), p=0.003), therefore, participants are 
lowering their CORE-10 score over time. The fixed effect of TIME is positive 
and highly significant for Mood (0.057 (0.008), p<0.001), with participants 
increasing mood score over the time in the group. 
 
2.4.3.2.3 The unconditional linear growth model (allowing slope variation, 
Model 3) 
TIME was added to the random effects in this model to investigate if individuals 
experience change differently. There was a significant improvement in model 
fit by allowing variation of intercepts with the -2LL reduced in the CORE model 
from 4355.738 to 4288.986 and Mood model from 3038.194 to 3013.159. 
There was a significant variation of the intercepts suggesting there is a spread 
of CORE-10 and Mood scores at the beginning and that individuals are starting 
from different points. The variation in the growth model between participants 
(slope variation term (UN(2,2)) is significant CORE =0.121 (0.036), z=3.356 
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(0.067, 0.217), p=0.001; Mood =0.003 (0.001), z=2.674 (0.002, 0.007), 
p=0.007, suggesting people are improving at different rates. The co-variance 
between slope and intercept is non-significant for both (CORE p=0.222, Mood 
p=0.922), suggesting there does not appear to be a relationship between 
someone’s initial score and their likelihood to experience change in CORE-10 
or Mood score. Furthermore, the fixed effect of TIME is still significant (CORE 
p=0.003; Mood p<0.001), therefore, the CORE-10 is reducing, and Mood score 
is increasing, over time with rates of change varying between individuals.  
 
2.4.3.2.4 Within-subjects variance autoregressive structure (Model 4) 
Within-subject variance was added to the model using an autoregressive 
structure to account for the corelation structure of within subject’s effects for 
the repeated measures scores, as these are likely to be non-independent, 
accounting for nuisance variance (Beaumont, 2012). This improved the fit 
further reducing the -2LL significantly for CORE 4235.700 and Mood 3000.946 
and the rho parameter was significant (CORE =0.363 (0.049), z=2.446 
(0.036, 0.180), p<0.001; Mood =0.003 (0.001), z=1.959 (0.001, 0.007), 
p=0.001) indicating there is a positive relationship in adjacent time points.  
 
2.4.3.2.5 Fixed effect of Group (Model 4a) 
The effect of CBASP-G was considered by fitting the Group number attended 
to the multilevel model and comparing the results with other CBASP studies 
(inpatient and individual modalities of treatment) (Guhn et al., 2021b; Swan et 
al., 2013). The level 3 factor of group the participant attended was introduced 
into the model. In the CORE model Group*TIME had a significant effect 
(p=0.003) and closer inspection the significance was from one group – Group 
9. Removing Group 9 kept the fixed effect of Group*Time significant but there 
were no groups showing significance. For the Mood model, full iteration was 
not achieved so the result was not reliable, as the validity of the model fit was 
uncertain. 
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2.4.3.2.6 Adding PPRF, PQ-SA, PQ-IDE to explain growth (Model 5) 
Next, the learning acquisition co-variates (PPRF, PQ-SA, PQ-IDE) were 
introduced into the model to investigate if competence in achieving this skill 
explained any difference in the growth models. Adding PPRF and PQ-IDE 
reduced the -2LL significantly, improving the model fit but the co-variants either 
alone or by TIME were not significant. Adding PQ-SA also gave a significant 
reduction in -2LL of CORE to 1113.452 and Mood to 777.903 and PQ-SA had 
a significant effect =-0.575 (0.246), (p=0.021) in the CORE model and 
PQSA*Time had a significant effect =0.012 (0.005), (p=0.022), though the 
fixed effect of Time became non-significant for both. IIP was added to the 
model but the iteration did not fully run, therefore, the model data was not 
reliable and are not reported. There may have been insufficient data since 
there was only 3 out of 21 timepoints at maximum available for each 
participant.  
 
Growth curve modelling was carried out to examine if the growth in skill 
acquisition measure was different to CORE and Mood linear change. PQ-SA 
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Figure 11. PQ-SA curve fit graph. 
 
PQ-IDE was also found to have quadratic change F(1,160.198)=10.291, 
p=0.002 (Figure 12.). 
 
Figure 12. PQ-IDE curve fit graph 
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PPRF was found to have quadratic fit F(1,496.416)=8.605, p=0.004 (Figure 
13.) 
 
Figure 13. PPRF curve fit graph
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Table 5. CORE-10 Multi-level modelling results 
  CORE MLM results     
Model Description       
1. Unconditional 
model 
Fixed effect /Estimate (SE) t p-value -2LL ICC  
Intercept 19.263 (0.844) 22.833 p<0.001 4385.517 0.644  
Variance  /Estimate (SE) z p-value    
Residual 21.675 (1.201) 18.052 p<0.001    




Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 2-1) p-value 
Intercept 20.710 (0.852) 24.359 p<0.001 4355.738 0.640 29.779, p<0.01 
Time -0.1823 (0.059) -3.123 p=0.003    
Variance  /Estimate (SE) z p-value    
Residual 20.697 (1.147) 18.044 p<0.001    





Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 3-2) p-value 
Intercept 20.782 (0.853) 24.539 p<0.001 4288.986 0.690 66.752, p<0.01 
Time -0.1828 (0.585) -3.123 p=0.003    
Variance  /Estimate (SE) z p-value    
Residual 16.911 (0.976) 17.325 p<0.001    





Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 4-3) p-value 
Intercept 20.820 (0.851) 24.477 p<0.001 4235.7 0.637 53.286, p<0.01 
Time -0.194 (0.056) -3.453 p=0.001    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 19.193 (1.465) 13.105 p<0.001    
Intercept (+ TIME) 33.653 (8.035) 4.189 p<0.001    
4a. Adding fixed 
effect of group 
Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 4a-4) p-value 
Intercept 18.489 (3.850) 4.820 p<0.001 4170.881 0.638 64.819, p<0.01 
Time -0.142 (0.206) -0.690 p=0.496    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 18.943 (1.420) 13.340 p<0.001    
Intercept (+ TIME) 33.373 (8.839) 3.776 p<0.001    
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Table 6. continued.  
 
      
5a. Adding PPRF 
to explain growth 
 
Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 5a-4) p-value 
Intercept 20.320 (1.904) 10.672 p<0.001 1777.409 0.756 2458.291, p<0.01 
Time -0.081 (0.177) -0.459 p=0.647    
PPRF 0.000 (0.025) 0.004 p=0.997    
PPRF*TIME -0.001 (0.002) -0.620 p=0.536    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 14.519 (1.569) 9.256 p<0.001    
Intercept (+ TIME) 45.001 (14.000) 3.215 0.001    
5b. Adding PQSA 
to explain growth 
 
Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 5b-4) p-value 
Intercept 22.816 (1.466)  15.558 p<0.001 1113.452 0.666 3122.248, p<0.01 
Time 0.142 (0.165) 0.861 p=0.392    
PQSA -0.575 (0.246) -2..338 p=0.021    
PQSA*TIME -0.032 (0.024) -1.325 p=0.189    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 16.37 (2.518) 6.501 p<0.001    
Intercept (+ TIME) 32.594 (9.403) 3.466 p=0.001    
5c. Adding PQIDE 
to explain growth 
 
Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 5c-4) p-value 
Intercept 21.166 (1.558) 13.590 p<0.001 1090.481 0.709 3080.4, p<0.01 
Time -0.122 (0.168) -0.726 p=0.471    
PQIDE -0.136 (0.228) -0.599 p=0.550    
PQIDE*TIME -0.003 (0.231) -0.142 p=0.887    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 16.569 (3.189) 5.196 p<0.001    
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Table 6. Mood score Multi-Level Modelling results 
  Mood MLM results     
Model Description       
1. Unconditional 
model 
Fixed effect /Estimate (SE)  t p-value -2LL ICC  
Intercept 5.116 (0.149)  34.285 p<0.001 3083.268 0.439 p<0.01 
Variance /Estimate (SE) z p-value    
Residual 1.726 (0.087) 19.943 p<0.001    




Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 2-1) p-value 
Intercept 4.648 (0.159)  29.224 p<0.001 3038.194 0.444 45.074, p<0.01 
Time 0.057 (0.008) 7.387 p<0.001    
Variance /Estimate (SE) z p-value    
Residual 1.623 (0.081) 19.939 p<0.001    





Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 3-2) p-value 
Intercept 4.667 (0.147)  31.698 p<0.001 3013.159 0.412 25.035, p<0.01 
Time 0.054 (0.011) 4.792 p<0.001    
Variance  /Estimate (SE) z p-value    
Residual 1.511 (0.078) 19.266 p<0.001    






Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 4-3) p-value 
Intercept 4.665 (0.147)  31.751 p<0.001 3000.946 0.371 12.213, p<0.01 
Time 0.054 (0.011) 4.846 p<0.001    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 1.576 (0.090) 17.551 p<0.001    
Intercept (+ TIME) 0.928 (0.269) 3.478 p=0.001    
5a. Adding 
PPRF to explain 
growth 
 
Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 5a-4) p-value 
Intercept 4.797 (0.373)  12.849 p<0.001 1400.99 0.546 1599.956, p<0.01 
Time 0.025 (0.036) 0.707 p=0.480    
PPRF 0.005 (0.006) 0.925 p=0.356    
PPRF*TIME 0.000 (0.000) 0.510 p=0.611    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 1.31 (0.117) 11.195 p<0.001    
Intercept (+ TIME) 1.576 (0.566) 1.329 p=0.184    
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Table 7. continued 
 
      
        
5b. Adding 
PQSA to explain 
growth 
 
Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 5b-4) p-value 
Intercept 4.394 (0.294)  14.955 p<0.001 777.903 0.490 2223.043, p<0.01 
Time -0.042 (0.033) -1.265 p=0.210    
PQSA 0.104 (0.054) 1.955 p=0.053    
PQSA*TIME 0.012 (0.005) 2.345 p=0.022    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 1.254 (0.180) 6.958 p<0.001    





Fixed effect /Estimate (SE) t p-value -2LL ICC 2 diff, (Model 5c-4) p-value 
Intercept 4.347 (0.321)  13.546 p<0.001 749.209 0.565 2251.737, p<0.01 
Time -0.002 (0.382) -0.052 p=0.959    
PQIDE 0.071 (0.049) 1.438 p=0.153    
PQIDE*TIME 0.007 (0.005) 1.307 p=0.194    
Variance  /Estimate (SE) z p-value    
AR1 diagonal Residual 1.073 (0.184) 5.848 p<0.001    
Intercept (+ TIME) 1.394 (0.536) 2.601 p=0.009    
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2.5.1 Main findings 
This study set out to investigate the effectiveness and change processes in a 
CBASP group run in a community setting, by modelling the change in skill 
acquisition and symptoms over the course of a 20-week group.  
 
2.5.1.1 Effectiveness of CBASP-G intervention 
The paired t-tests confirm that the CBASP-G intervention leads to a significant 
reduction in depression symptoms (BDI-II) with a large effect size, a significant 
decrease in overall distress (CORE-10) with a medium effect size and a 
significant medium to large effect size of improvement in self-reported mood 
score. The multilevel modelling indicated that the change in Mood and CORE-
10 score was linear and not quadratic, aligning with Bird, (2016) and 
suggesting that symptom change happens steadily during CBASP-G. The 
unconditional models highlighted a substantial variance between participants 
for CORE-10 and Mood scores and that the starting score was not indicative 
of the subsequent rate of change. Adding time into the model significantly 
improved the fit indicating that Mood and distress (CORE-10) significantly 
improved during the group. Adjusting the model to allow slope variation by 
adding time into the random effects showed that patients experience change 
differently. They start at differing levels of distress and Mood scores and 
improve at different rates, while the initial Mood or CORE-10 score did not 
affect the pattern of change. The addition of the auto-regressive structure 
again improved the model fit significantly and as expected highlighted the 
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The global functioning scores (PGI, CGI-I and CGI-S) indicated there was 
significant overall improvement while the majority of participants (88.2%) had 
reductions in their self-rated severity of symptoms with the rest having no 
change. The clinician rating (PGI) indicated significantly that 70.5% improved 
with the others having no change.  
 
2.5.1.1.1 Interpersonal functioning 
Not enough data was present to add the interpersonal measures to the model. 
The change in overall interpersonal functioning as measured by the IIP-32 was 
not significant, however, there was significant change in the domain Hostile-
submissive and this linked to decrease in depression scores which fits with 
previous research (Bird et al., 2018, Constantino et al., 2008; Constantino et 
al., 2012). It is possible that the missing data left this measure under powered 
and since change is likely to continue post group (Arnow et al., 2000, Arnow & 
Constantino, 2003), it may improve over time after the group ends.  
 
2.5.1.2 Acquisitional learning and symptom change 
Adding the measures of learning acquisition to the model improved the fit and 
helped explain significantly more of the variance between participants. The 
addition of PPRF and PQ-IDE did not have a significant fixed effect however, 
possibly due to a low sample size and not enough power, or perhaps due to 
this part of learning taking longer to deliver symptom change. Discriminating 
others more generally from the SO is likely to be a process of building trust 
with the therapist, the group and then testing this more generally which might 
take longer than the change in behaviour with the PQ-SA. Since, this measure 
was changed at Group 8 to include others more generally the results of this 
are inconclusive. The PQ-SA did have a significant impact on both the CORE-
10 and Mood models and explained more of the variance making Time non-
significant. For the CORE-10 model the PQ-SA achievement was stable over 
time but for Mood the association of PQ-SA was over time. This suggests that 
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the measure of learning acquisition is more important to change in CORE-10 
score than the other elements added; time becomes less important due to the 
large variance caused by the additions of PQ-SA and IDE. A larger sample 
with more power and longer follow up might show significance for Time too. 
This fits with the evidence that achievement of core skill of CBASP has an 
effect on improving symptoms (Klein et al., 2011; Santiago et al., 2005). 
 
 McCullough’s (2020) graph of skill acquisition and depression change (Figure 
7.) does not represent the findings in this study. Change in symptoms (CORE-
10 and Mood) was found to be linear not quadratic as depicted by McCullough 
(2020). However, the linear change in symptoms did fit with previous research 
by Bird (2016). This indicates that the change in symptoms is steadier through 
therapy. The skill acquisition change was quadratic in nature, and this points 
to the learning being quite steep at the start to middle of therapy and then 
levelling off, as might be expected as there is a ceiling to the measures of 
learning a skill. As the person implements their learning in daily life, gradually 
over time, this leads to symptom change. This shows us that while skills 
acquisition levels off towards end of therapy the symptoms keep changing 
steadily.  
 
2.5.1.3 Group effect 
Adding the fixed effect of Group into the model had mixed results. An initial 
effect of Group over time appeared significant for one group (Group 9) and on 
further investigation it was discovered that all but one participant dropped out 
of that group by midpoint of therapy, so the last participant had in effect 1-1 
CBASP rather than group CBASP for the last half of therapy. This is likely to 
have skewed the effect of group, and on removing Group 9 there was no 
significant group effect. This may highlight that group membership has some 
effect on outcome, and indeed there will be different drop-out rates for each 
group.  
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2.5.2 Theoretical implications 
These findings broadly fit with the evidence base that CBASP is effective for 
reducing depression and distress and increasing mood of participants 
(Furukawa et al., 2018; Keller et al., 2000; Kriston et al., 2014; Negt et al., 
2016; Schramm et al., 2011; Wiersma et al., 2014) and that this group format 
of CBASP in an outpatient setting is effective (Locke et al., 2016; Michalak et 
al., 2015; Sayegh et al., 2012; Saba et al., 2017).  
 
The change in the interpersonal domains of hostile, submissive and hostile 
submissive support the findings of previous research that interpersonal 
change happens as a result of CBASP treatment and that these are the key 
areas of relevance to PDD (Bird et al., 2018; Constantino et al., 2008; 
Constantino et al., 2012; Köhler et al., 2019). However, only the hostile-
submissive domain reached significance and it is possible that the sample was 
not big enough to detect changes in hostility or submissiveness independently. 
The effect size of change in hostile-submissive rating was slightly higher than 
Guhn et al.’s (2021b) study of group CBASP in an inpatient setting (in this 
study d=0.673 versus d=0.625 in Guhn et al., 2021b). This is interesting since 
the dose of therapy was higher in the inpatient study (24 individual and 24 
group sessions over 12 weeks) and might indicate the inpatient sample 
needed a higher number of sessions to match the interpersonal change seen 
in this sample, possibly due to higher severity of symptoms. The finding that 
hostile-submissive traits were reduced by CBASP-G adds weight to the theory 
that becoming competent at the SA, and being more skilled interpersonally, 
helped improve symptoms (Klein et al., 2011; Santiago et al., 2005). It is 
possible that positive changes in the therapeutic relationship facilitated this 
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The effect of the group attended was inconclusive, and this highlights the 
importance of the selection of participants suitable for groups. COVID-19 had 
an impact on the last group with it being held mostly over the phone and online. 
This could be a factor in the last group experiencing more distress due to the 
pandemic or give fewer opportunities to experience the impact of group effects 
and practice interpersonal learning in social situations. Little is known about 
the differences that the group element might have brought, and further studies 
could investigate patient experiences qualitatively (Guhn et al., 2021b). 
 
The multilevel modelling indicated that skill acquisition explained a large part 
of the variance, but larger samples and/or a longer follow up may be needed 
to give greater clarity to this result and to review if other interpersonal domains 
reduce, and PQ-IDE and PPRF reach significance. The dropout rate for this 
study was substantial and this fits with the evidence that people with PDD are 
more likely to discontinue treatment for various reasons, such as inferior social 
support or higher side effects of medication linked to CM (Keller et al., 2014; 
Medeiros et al., 2021). The issues with many different confounding factors and 
moderators persists and any conclusions are tentative (Jobst et al., 2015; 
Kraemer, 2013). The findings are limited as the impact of the intervention 
cannot be separated from aspects such as the group setting, peer interaction, 
co-morbid mental health conditions, early onset depression, CM, social 
support and many more factors. 
 
2.5.3 Strengths and Limitations 
This study has some strengths; this is a “real life” clinical example of bringing 
theory from RCT evidence into practical therapy for people with PDD in the 
community. There was data from a substantial number of participants (80) and 
the use of multilevel modelling helped maximise the information gained. This 
is an example of clinical trials put into real life therapy situation with participants 
not excluded from treatment due to co-morbidities or health conditions (Angst 
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et al., 2008; Murphy & Byrne, 2012; Pettit et al., 2008; Trivedi et al., 2006). 
Assessments in outpatient settings do not have exclusion criteria comparable 
with clinical trials; suicidality, co-morbid physical and mental health conditions 
are the norm especially for those with PDD (Schramm et al. 2017). The skill 
and diligence of the therapists to engage and maintain this intensive therapy 
using DPI is an important strength of this study. DPI is likely to help people 
with several co-morbidities to engage in treatment, which is important with 
PDD being a difficult to treat presentation (McCullough, 2006).  
 
Limitations of this study include that the outcome measures are mainly self-
report, subjective and there may be a bias in the patient wanting to please the 
therapist, or the therapist rated scores being inflated. The PPRF filled in by the 
therapists to assess how well the patient has completed their SA not what their 
actual functioning is. It is possible that a person could be competent at filling 
these in and score well in session, but still be functioning poorly in real-life.  
Though, the remediation of the SA in session helps the patient understand how 
they might achieve their desired outcome next time so demonstrating that 
learning leads to symptom change.  A limitation of the SA is that it is dependent 
on the person’s choice of interpersonal difficulty; the subjective choice of an 
“easy” or “hard” one means there will be variance in the scores (Santiago et 
al., 2005). Moreover, this study measured distress (CORE-10) and Mood and 
therefore, did not mirror McCullough’s (2020) theorised change in depression 
symptoms. There is a considerable amount of missing data in this sample, due 
to the “real-world” circumstance of this study and that people might drop-out 
due to feeling better, or feeling worse, or feeling apathetic about the group. 
Although the data was deemed to be missing at random, it would be helpful to 
know reasons for dropout to be able to assess this in more detail. A more 
robust examination on the patterns of missing data and the likely effect of this 
would give greater understanding of the validity of the research findings. 
Additionally, the lack of follow up data means that any improvement gained 
after the group as expected is not captured (Schramm et al., 2019). The length 
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of intervention at 20 weeks is lower compared to Schramm et al. (2017) with a 
total contact time of 48 weeks and drop-out rates appear to be high. This is an 
important point since interpersonal change is expected to continue to deliver 
improvements in symptoms after the 20 weeks of therapy finishes. The linear 
change in symptoms could have a different curve fit over a longer follow up 
period and this means the measures should be collected for substantially 
longer to understand the full impact of learning on reducing distress and 
improving mood.  
 
Due to the post-hoc nature of this study, there was little demographic 
information available and there are many variables that cannot be accounted 
for. It is possible that some participants were on varying anti-depressant 
medication and had a bigger burden of side effect or that some of the side 
effects are mirrored in depression outcome BDI-II (Hieronymus et al., 2021; 
Medeiros et al., 2021). It is not known what percentage of participants had a 
CM history since there was no measure of CM taken, and information was not 
collected on early-onset depression, (Klein et al., 2015; Nelson et al., 2017) or 
if participants had less severe symptoms and higher quality of life; therefore, it 
is possible that some of these individuals would have benefited from a different 
type of therapy such as supportive therapy as in Schramm et al. (2017). 
Conversely, the opposite could be true, that the sample had more CM and that 
this stopped them from making progress in CBASP (Bausch et al., 2017; Nanni 
et al., 2012). Baseline interpersonal style might also affect the efficacy of the 
group. If a higher proportion of hostile-dominant types in the sample some may 
have benefited from a different type of therapy, and this was not examined 
(Probst et al., 2020). Indeed, there were several challenges presented working 
with a secondary dataset (rather than planned research) that were unavoidable 
due to COVID-19 but would have impacted on the robustness of this research. 
These include the control and consistency of the measures selected, having 
follow up data, the ability to source missing data with expedience, greater 
access to demographic and clinical information and the ability to examine 
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broader research questions. These factors would have added a depth to the 
analysis and given the research greater focus and very possibly clearer results 
which could inform current knowledge and future research directions in a more 
potent way and the secondary nature of the dataset should be considered a 
major limitation for this study. 
 
2.5.4 Future research 
There are many areas of interest to be pursued following this study. An 
analysis of dropouts and missing data could investigate the reasons involved. 
Issues such as the impact of anti-depressant use, CM, early versus late onset 
of depression, baseline quality of life and interpersonal type scores are 
important variables that have not been considered here but are likely to have 
had some impact. Further studies should examine any group effects in detail 
and the long-term efficacy and efficacy of maintenance groups. (Arnow & 
Constantino, 2003). This would help focus the CBASP-G delivery to those that 
are most likely to benefit and fits with the suggestion that individual tailoring of 
treatment could bring better results (Furukawa et al. 2018). Patient preference 
for type of therapy could be considered to improve efficacy and drop-out rates 
(Mergl et al., 2011; Swift et al., 2011; Williams et al., 2016). Additional studies 
could look at using a short measure like the PHQ-9 to assess depression 
symptoms to model change and using an independent rater would add weight 
to measures such as the PPRF and depression measures, though it is 
acknowledged that this would be hard to implement in every-day practice.   
 
In summary, CBASP-G was found to be an effective intervention for improving 
mood and overall distress for individuals presenting with persistent depression 
in a community setting. Skill acquisition was found to be an important factor in 
the reduction of symptoms across therapy. It is vitally important that 
interventions are finely tuned using robust evidence so persistently depressed 
people in our communities get the support they need. Furthermore, this 
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assistance should be of the correct dose and maintenance support offered as 
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Appendix A. Funnel plots of meta-analysis 
  
Funnel plot of Indvidual and groups 
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Funnel plot of Indvidual and groups and active inactive controls 
 
 
Funnel plot of Indvidual and groups by risk 
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Funnel plot of inactive and active controls 
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Appendix B. Forest plots from meta-analysis. 






Effectiveness and change processes in CBASP-G for PDD.
  123 








Effectiveness and change processes in CBASP-G for PDD.
  124 







Effectiveness and change processes in CBASP-G for PDD.
  125 










Effectiveness and change processes in CBASP-G for PDD.
  126 










Effectiveness and change processes in CBASP-G for PDD.
  127 
Appendix C. Interpersonal Circumplex  
Interpersonal circles 
Autocratic = dominant/controlling 
Overly expressive = friendly-dominant/intrusive/needy 
Overly nurturant = Friendly/self-sacrificing 
Exploitable = Friendly-submissive/overly accommodating 
Non-assertive = submissive 
Socially avoidant = Hostile-submissive/socially inhibited. Avoidant 
Cold = Hostile/distant 
Competitive = Hostile-dominant/vindictive/self-centred 
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Appendix D. CBASP-G Protocol. 
Session Date Activity Action Completed FOR NON-DPI 
Did opportunity for DPI arise? 
Which component? 
1  Timeline and SOH -PHQ 
-Check that CBASP manual has been 
received 
-Check reaction to manual 
 
Yes / No 
Yes / No 
 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
2  Timeline and SOH -PHQ 
-Timeline completed 
-SOH completed 
-PQ-SA (see instructions)(Patient 
inserts in sealed envelope and 
therapists puts envelope in file) 
-After Session 2 therapist completes 
IMI to be shared in Session 3 
Yes / No 
Yes / No 
Yes / No 





Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
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 Yes / No 









-Share IMI (1) 
-Working Alliance Inventory (Patient 
and Therapist) completed at end of 
session 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
4  IMI -PHQ 
-PQ-IDE(1) (see instructions)(Patient 
inserts in sealed envelope and 
therapist puts envelope in file) 
-Letter to referral source 
 
Yes / No 





Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 








Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
 






Session Date Activity Action Completed FOR NON-DPI 
Did opportunity for DPI arise? 
Which component? 
2. CPR 
3. Modelling Empathy & 
Intimacy 





-PQ-SA(2) (Patient inserts in sealed 
envelope and therapist puts envelope 
in file) 
 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 







--Working Alliance Inventory (Patient 
and Therapist) completed at end of 
session 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
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8  SA and/or IDE 
(DPI) 
-PHQ 
-PQ-IDE (Patient Inserts in sealed 




Yes / No 
Yes / No 
 
 
Yes / No 
Yes / No 
 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 






Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
10  SA and/or IDE 
(DPI) 
-PHQ 
-PQ-SA (3) (Patient inserts in a sealed 
envelope which goes in file) 
--SA Completed 
-PPRF Completed 
Yes / No 
Yes / No 
 
 
Yes / No 




Effectiveness and change processes in CBASP-G for PDD.  132 
 
Yes / No 
Yes / No 
 
3. Modelling Empathy & 
Intimacy 




-PPRF Completed  
Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
12  SA and/or IDE 
(DPI) 
-PHQ 
-PQ-IDE (3)(patient inserts in sealed 




Yes / No 




Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
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-Working Alliance Inventory (Patient 
and Therapist) completed at end of 
session 
 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
14  SA and/or 
IDE(DPI)* 
-PHQ 
-PQ-SA (4)(patient inserts in sealed 




Yes / No 




Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
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Session Date Activity Action Completed FOR NON-DPI 
Did opportunity for DPI arise? 
Which component? 




Yes / No 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
16  SA and/or IDE (DPI) -PHQ 
-PQ-IDE(4)(patient 
inserts in sealed envelope 
and therapist puts 




Yes / No 




Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
17  SA and/or IDE (DPI) -PHQ Yes / No Yes / No 
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 --SA Completed 
-PPRF Completed 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
18  SA and/or IDE (DPI) -PHQ 
-PQ-SA(5)(patient inserts 
in sealed envelope and 
therapist puts in file) 
--SA Completed 
-PPRF Completed  
Yes / No 
Yes / No 
 
 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
19  SA and/or IDE (DPI) 
Working Alliance (4) 
-PHQ 
-IMI(2) – therapist 





Inventory (Patient and 
Yes / No 
Yes / No 
 
 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
3. Modelling Empathy & 
Intimacy 
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Therapist) completed at 
end of session 
Yes / No 
20  SA and/or IDE(DPI)* 




inserts in a sealed 
envelope and therapist 
puts in file) 
 
Yes / No 
Yes / No 
Yes / No 
If yes, circle: 
1. IDE 
2. CPR 
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 ISSUES ARISING FROM THE PROPOSAL 
Reviewer Comments 8.3.21 
 
There seems to be inconsistent data in the application and granted by caldicott.  In the application above you 
mention SMID also lots of clinical measures.  
 
The caldicott approval states gender, age and CHI numbers.  Is it through the CHI numbers that you will obtain the 
clinical measures and SMID?  Please clarify.  
 
 
The applicant should respond to these comments in section below. 
 
Signature: Position:  Ethics and Integrity Lead  
Date:  8.3.21 
 
 APPLICANT’S RESPONSE (If required) 
The age will be provided from the CHI numbers before anonymisation, so in effect I will not be accessing CHI as this 
will be done by someone in the service. The gender and SIMD will be provided to me as per the Caldicott approval in 
the anonymised form. As stated above Q 43. “Basic demographic information (CHI, age, gender, SIMD)”. All the other 






 CONCLUSION TO ETHICAL REVIEW (if required) 
 
The applicant’s response to our request for further clarification or amendments has now satisfied the requirements 
for ethical practice and the application has therefore been approved. 
 
 
Signature:   
Position: Lead in Ethics and Integrity/Lecturer in Applied Psychology  
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Appendix F. Caldicott ethical approval letter. 
 
 
